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ABSTRACT
The CCR4-NOT transcriptional regulatory complex affects expression of a 
number of genes both positively and negatively. This study demonstrates that the CCR4- 
NOT complex functionally and physically interacts with TBP and TAFs. Firstly, 
mutations in CCR4. NOT4. and NQT5 suppressed the his4-912 delta insertion by a 
mechanism similar to that observed for the defective TBP allele sp tl5-122. This 
mechanism appeared to involve stabilization of TBP binding to a specific non-consensus 
TATA sequence, CATAAA, in the his4-912 delta element. Secondly, using modified 
HIS3 promoter derivatives containing specific mutations within the TATA sequence, it 
was found that the NOT proteins were general repressors that disrupt TBP function 
irrespective of the DNA sequence. Thirdly, increasing the dosage of NOT 1 specifically 
inhibited the ability of spt!5-122 to suppress the his4-912 delta insertion but did not 
affect the Spt-phenotype of either spt3 or sptlO at this locus. Fourthly, spt3. spt8 and 
sptl 5-21 alleles ( all involved in affecting interaction of SPT3 with TBP) suppressed 
ccr4 and cafl defects. Also, a number of genetic interactions were observed between 
CCR4-NOT complex components and TBP and TAFs
vm
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In addition, NOT2 and NOT5 were found to physically interact with TBP, 
multiple TAFs, and SPT3. Moreover, NOT2 and NOT5 were found to associate with 
components from purified SAGA and TFDD complexes, respectively. These genetic and 
physical interactions indicate that one role of the CCR4-NOT complex is to inhibit 
functional TBP-DNA interactions, perhaps by interacting with and modulating the 
function of factors which associate with TBP such as the components of TFHD and 
SAGA.
ix
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INTRODUCTION
Controlling the rate of RNA synthesis within the cell must be highly coordinated. 
Three different polymerases are used to transcribe rRNA, mRNA and small RNAs. Since 
the TATA Binding Protein (TBP) is the only factor that is shared among all three types of 
polymerases that transcribe these genes, it is a likely target for regulation of transcription 
by all three polymerases (Lee and Young 1998). In addition, the cell needs regulatory 
systems to modulate gene specific and global transcription in response to environmental 
stimuli. Since TBP binding to the TATA element is a rate limiting step for transcription 
of RNA polymerase II (Pol II) genes, several mechanisms for regulating transcription 
have evolved that target this process.
A number of factors have been identified that physically associate with TBP and 
stabilize its binding to DNA and are required for optimal TBP function at a subset of 
promoters. These factors include TAFs, TFIIA SPT3 and SPT8 (Hampsey 1998).
TAFs (TBP Associated Factors)
TBP is known to exist in at least four different complexes SL1, TbiiD, r n l lK 
and SNAPc that function in the expression of Pol I specific, Pol II specific, Pol III 
specific and small RNA genes respectively (Lee and Young 1998). TFILD which is 
involved in Pol II transcription consists of TBP and thirteen different TAFs (S.Habn 
1998). In vitro, TAFs were found to be dispensable for basal transcription but were 
essential for activated transcription (Pugh et al 1992). Therefore, TAFs were considered 
to be mediators of activated transcription. Consistent with this TAFs have been shown to
1
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contact the activation domains of several different activators, bind other general 
transcription factors, and interact with promoter elements (Burke et al 1997; Chen et al 
1994; Goodrich et al 1993; Verrijzer et al 1996). Thus TAFs were proposed to function 
as co-activators that convey information from the activators to the core transcription 
machinery. Recent studies done in yeast indicate that although TAFs are essential for 
viability, they are not required for activated transcription of several genes in vivo 
(Moqtaderi et al 1996; Walker et al 1996). It has also been reported that certain TAFs 
such as TAF130 bind DNA and function as promoter selectivity factors (Shen et al 1997). 
A subset of TAFs including TAFn130, TAFn19, TAFn47, and TAFn40 have been shown 
to be required for optimal expression from promoters containing non-consensus TATA 
elements, such as the Tc element of the HIS3 promoter and the TRP3 promoter 
(Moqtaderi et al 1996, 1998).
Another subset of TAFs consisting of the proteins that contain the “histone fold” 
motif, including TAFn61, TAFn60 and TAFn17 have been reported to be required for the 
expression of a large subset in the yeast genome and are also important for activated 
expression for activated transcription of several inducible genes (Holstege et al 1998; 
Micheals et al 1998). These histone fold containing TAFs are components of multiple 
transcription regulatory complexes including TF11D and SAGA. The mechanisms of 
action of these TAFs remains unclear.
SAGA ( Spt Ada Gcn5 Acetyl transferase)
SAGA is a large co-activator complex. It consists of at least three known classes 
of proteins involved in transcriptional regulation. Proteins from each class are known to
2
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interact with TBP and are thought to stabilize its binding to DNA (Sterner et al 1999). 
The three classes of proteins include the ADA proteins, the SPT proteins and a subset of 
TAFs. The ADA proteins consist of ADA2, ADA3, ADA5/ SPT20 and GCN5 which is 
an histone acetyl transferase that acetylates specific lysine residues in the amino-terminal 
tails of the H3 and H4 histones (Berger et al 1992; Horiuchi et al 1995; Marcus et al 
1996; Brownell et al 1996). This activity of GCN5 is essential for its co-activator 
function and is thought to alter nucleosome structure so as to allow increased access of 
transcription factors to DNA. The ADA proteins have also been shown to function as 
adaptors, bridging interactions between activation domains and components of the core 
transcription machinery (Bariev et al 1995). The TAFs that are part of SAGA include 
TAFn90, TAFn23 and the previously mentioned histone-like TAFs (Grant et al 1998). 
The role of these TAFs in the SAGA complex remains unclear.
The SPT proteins that are part of SAGA include SPT3, SPT7, SPT8 and SPT20 
(Grant et al 1997). Mutations in these SPT genes have effects similar to specific 
mutations in TBP, on transcription from certain promoters (Winston et al 1984; Winston 
1992). Isolation of allele specific suppressor mutations in SPT3 and TBP suggested a 
physical interaction between these two proteins which was subsequently confirmed by 
biochemical studies (Eisenmann et al 1994). A recent report indicates that SPT8 is 
essential for interaction between the SAGA complex and TBP (Sterner et al 1999). It is 
thought that SPT3 and SPT8 function to stabilize TBP binding to DNA and are important 
for TBP function at certain promoters (Eisenmann 1994; Madison 1997).
3
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TFIIA
TFIIA is another factor that functions to stabilize TBP binding to DNA. TFIIA 
was initially identified as a general transcription factor since it was essential for 
transcription in in vitro systems using partially purified preparations of transcription 
factors (Reinberg et al 1987). Recent reports indicate that TEHA is dispensable for basal 
transcription but is required for TFILD dependent activated transcription (Ozer et al 1994; 
Sun et al 1994). TFIIA has been shown to bind TBP-DNA complexes and form a stable 
ternary complex (Buratowski et al 1992; Imbalzano et al 1994). TFIIA has also been 
shown to interact with specific activators and certain TAFs (Sun et al 1994; Yokimori et 
al 1993). Recent evidence indicates TFIIA has an “Anti-Repression” function (Ma et al
1996) wherein it displaces TBP specific repressors like MOT1 and the NC2 complex 
from TBP or TFIDD.
TBP specific repressors also play important roles in regulating global 
transcription as well as gene-specific transcription in response to environmental stimuli. 
This class of repressors includes MOT1 and the NC2 complex. Deletion of any one of 
these genes is lethal, emphasizing the importance of repressing TBP function.
MOT1
MOT1 functions to dislodge TBP from DNA in an ATP dependent manner 
(Auble et al 1993, 1994). MOT1 has ATPase activity that is essential for this function. 
Recent evidence suggests that MOT1 redistributes TBP between functional and non­
functional TATA elements (Auble 1999). The TBP dislodging activity of MOT1 can be 
counteracted by TFIIA and mutations in MOT1 are synthetic lethal with TFIIA or SPT3
4
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mutations (Madison et al 1994). This suggests that defect in MOT1 function reduces 
recruitment of TBP to functional TATA elements and TFIIA and SPT3 can partially 
offset this by stabilizing TBP binding to functional TATA elements.
NC2 complex
The NC2 complex has been shown to bind TBP and prevent access of TFIIA and 
TFilB (Goppelt et al 1996a, 1996b). The NC2 complex is a heterodimer consisting of 
NC2 alpha and NC2 beta (Goppelt 1996b). Mutations in NC2 components allow the 
expression of several genes under repressing conditions (Prelich 1997). Overexpressing 
NC2 causes toxicity that can be alleviated by overexpressing TBP (Kim et al 1997). 
These data support the role of NC2 in modulating TBP availability at certain promoters. 
A role for NC2 in regulating global transcription is suggested by the fact that mutations 
in NC2 components can suppress the global transcription defects caused by an srb4 
temperature sensitive mutation (Gadbois et al 1997).
SRB4 is an essential component of the RNA polymerase n holoenzyme. 
Mutations in SRB4 cause a rapid and dramatic drop in polyA transcript levels, when 
shifted to non-permissive temperature (Thompson et al 1995). Mutations in NC2 were 
found to suppress this effect. Other mutations that were isolated as suppressors of srb4-ts 
and therefore, likely to have global roles in transcription regulation include, notl. not3 
and cafl (Lee et al 1998) These genes encode components of the CCR4-NOT 
transcription regulatory complex.
5
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CCR4-NOT complex
CCR4 was originally isolated as a factor required for optimal expression of the 
ADH2 gene (Denis 1984). Since then it has been shown to affect the expression of 
several genes including other genes involved in non-fermentative metabolism, genes 
involved in maintenance of cell-wall integrity, methionine biosynthesis and genes 
involved in DNA repair (Malvar and Denis 1992; Schild 1995; Mckenzie et al 1993; 
Tabtiang and Herskowitz 1998; Collart and Struhl 1993; Lee et al 1998; Liu et al 1998; 
Benson et al 1998). CCR4 exists as part of a large protein complex. Several components 
of this complex have been identified, including CAF1, DBF2 and recently the NOT 
proteins, NOT1 through NOT5.
The NOT genes were isolated as repressors of “Tc” initiated HIS3 transcription 
(Collart et al 1993; Collart et al 1994). As seen in Figure 2, the HIS3 promoter contains 
two important elements, “TR” which consists of the canonical TATA sequence and is 
known to be required for activated transcription, and “Tc” which confers constitutive 
expression and consists of a long, ill-defined sequence containing several non-consensus 
TATA sequences. The NOT genes were isolated as mutations that cause increased 
transcription from the Tc element, in the presence of a weak activator (Collart et al 1993; 
Collart et al 1994). However it was not known whether this effect was specific to the Tc 
element or if it affected TBP binding to DNA. Further, the not mutations did not display 
any significant effects on HIS3 transcription in the presence of a strong activator GCN4 
(Collart et al 1993; Collart et al 1994). GCN4 is a DNA binding acidic activator that 
activates transcription of several genes involved in amino acid biosynthesis including
6
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HIS3 (Chen et al 1989). As described previously (Liu et al 1998, Appendix 1), the CCR4- 
NOT complex affects gene expression both positively and negatively. The CCR4-NOT 
complex consists of CCR4, CAF1, NOT1, NOT2, NOT3, NOT4, NOT5 and other 
proteins that are currently being characterized in the Denis lab.
The CCR4 protein contains a cluster of five Leucine Rich Repeat (LRR) motifs 
which are known to be involved in mediating protein -protein interactions (Suzuki et al 
1990; Lee et al 1990; Draper et al 1994).CAF1 was isolated in a genetic screen for 
proteins that interact with CCR4 protein (Draper et al 1995). Both CCR4 and CAF1 when 
mutated display very similar phenotypes such as caffeine sensitivity, inability to grow on 
non-fermentative carbon sources at 37*C and reduced expression of ADH2 under 
derepressed conditions (Draper et al 1995; Liu et al 1998). CAF1 was also independently 
isolated as a negative regulator of PGK expression in stationary phase (Sakai et al 1992). 
NQT1, NOT2 and NQT4 have been previously isolated as mutations that allow the 
expression of pheromone inducible genes in
7
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Figure 1: Schematic diagram of the normal HIS3 promoter and its derivatives.
The structure of the HIS3 promoter as described in Harbury et al 1989 is shown. 
Top : The GCN4 binding site, and Tc and TR TATA elements are indicated with respect 
to the +1 mRNA initiation site.
Bottom : wild type - modified HIS3 promoter containing a single TATA element ( 
Harbury and Struhl 1989) wherein the Tc and TR elements have been replaced by the 
indicated sequences.his3-202. -205. -208. and -217 - same as wild type except the 
TAT AAA element has been altered as indicated in bold.
8
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the absence of pheromone stimulation (Cade et al 1994; Barros Lopes 1990). As a result, 
transcription of FUS1 which is normally repressed in the absence of pheromone 
stimulation is increased in strains mutated for these not genes (Cade et al 1994).
NOT1 is a large protein consisting of 2108 amino acids and is the only protein 
within the CCR4-NOT complex that is essential for viability (Collart 1994). The LRR 
region of CCR4 is necessary and sufficient for interaction between NOT1 and CCR4 
(Draper et al 1994; Liu et al 1998). NOT1 migrates as a doublet of 195 kD and 185 kD. It 
has been shown that the smaller species is an N-terminal truncation (Liu et al 1998). Both 
species have been shown to interact with CCR4 (Draper et al; Liu et al 1998).
NOT2 is a small protein of 192 amino acids. Among the NOT genes, deletion of 
not2 has the most dramatic effects on ADH2 expression (Liu et al 1998, Appendix). The 
close functional and most likely physical interaction between NOT1 and NOT2 is 
indicated by the fact that the notl-2 mutation is specifically suppressed by the not2-4 
mutation (Collart 1994) . A recent report indicates that the evolutionarily conserved C- 
terminal region of NOT2 is involved in functions similar to and overlapping with CCR4, 
while the N-terminus of NOT2 is involved in a distinct function (Benson 1999).
NOT4 encodes a protein of 587 amino-acids and contains a putative RING finger 
motif. RING finger motifs have previously been shown to be involved in mediating 
protein-protein interactions (Saurin et al 1996; Meza et al 1999). As stated earlier, NOT4 
was isolated as a mutation that causes constitutive expression of the FUS1 gene, in the 
absence of pheromone stimulation. This phenotype is also conferred by a dominant 
negative allele of NOT4. when it is overexpressed (Cade et al 1994). The dominant
9
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negative effects of NQT4 alleles indicates that altering the dosage of the NOT genes can 
affect gene expression.
NOT3 and NQT5 were isolated as mutations that increase HIS 3 transcription 
from the Tc element (Collart 1994; Oberholzer et al 1998). NOT3 and NOT5 show 44% 
identity in their amino-acid sequence, in the N-terminal region (Oberholzer 1998). Unlike 
the other NOT genes, deletion of NQT3 does not cause temperature sensitivity or caffeine 
sensitivity and has no effect on ADH2 expression (Liu et al 1998, Appendix 1). However 
the not3-2 allele displays the most dramatic increase in Tc dependent transcription 
(Collart 1994), indicating that individual components of the CCR4-NOT complex can 
affect the expression of different genes, dissimilarly.
Since the NOTs can distinguish between Tc and TR, the NOT proteins were 
suggested to restrict TBP access to non-canonical TATA sequences. Collart (1996) 
further showed that certain not alleles genetically interacted with MOT1 which is 
required for TBP removal from DNA (Auble et al 1994) and with SPT3, which binds 
TBP (Eisenmann et al 1992) and is required for its action at certain promoters. Although 
the results from most studies are consistent with the possibility that the NOTs function by 
regulating TBP activity, the mechanism of action of the CCR4-NOT complex remains 
unclear.
The focus of this dissertation is to investigate the model, that the CCR4-NOT 
complex functions by regulating TBP activity, and to elucidate the mechanism(s) of 
action of the CCR4-NOT complex
10
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In the research presented here, I have assayed NOT function, in vivo, using strains 
that contain simplified HIS3 promoter derivatives containing specific mutations within 
the TATA sequence. Specifically I tested the effect of not mutations on activated HIS3 
transcription, from mutant (non-consensus) TATA sequences that vary by a single base 
pair. From this analysis it was found that the NOT proteins are general repressors that 
reduce TBP activity irrespective of the sequence to which TBP binds. In addition, we 
have also obtained evidence that ccr4 , cafl. not4 deletions affect his4-912 delta 
expression in the same manner as certain TBP mutations. Biochemical analysis indicated 
that NOT2 and NOT5 can immunoprecipitate and retain TBP, TAFn130, TAFn90, 
TAFn61, TAFn60, TAF^O, TAFn25 and SPT3. Using purified complexes, it was 
demonstrated that NOT5 retained several components from TJtTLD while NOT2 
associated with components of SAGA. It was also shown that TBP and TAFs displayed 
multiple genetic interactions with CCR4-NOT complex components. These genetic and 
physical interactions indicate that one role of the CCR4-NOT complex is to inhibit TBP 
activity, perhaps by interacting with factors which associate with TBP such as the 
components of TFUD and SAGA and thereby modulate their function.
11
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MATERIALS AND METHODS
Genetic analysis
Nutrient auxotrophies and suppression of delta insertions at the HIS4 locus were 
scored on his-medium supplemented with the appropriate amino acids, as described in 
Arndt et al 1994. Phenotypic analysis of the modified HIS3 promoters was carried out by 
testing growth of strains on media containing 3-aminotriazole (3-AT), as described in 
Arndt et al 1994.
Gene disruptions and plasmids
The plasmids and gene disruption constructs used have been described previously 
(Liu et al 1998; Collart and Struhl 1994; Oberholzer et al 1998; Madison and Winston
1997). All the TAFn overexpression plasmids used in this study were a gift from S. 
Buratowski and were expressed from the native promoters on 2 micron plasmids. 
Immunoprecipitation
Immunoprecipitations were carried out as described previously (Draper et al 
1994; Liu et al 1998) with yeast extracts prepared in Ip/wash buffer containing 50 mM 
phosphate, pH 7.6, 1 mM Sodium pyrophosphate, 1 mM Sodium fluoride, 1% NP40,
10% glycerol, 2 mM Magnesium chloride, 1 mM EDTA, 4 mg/L Leupeptin, 2 mg/L 
Pepstatin A, 1 mM Benzamidine, 1.25 mg/L Chymastatin, 1 mM PMSF. 2 mg of yeast 
crude extract protein in 250 microlitres of Ip/wash buffer was incubated either with 5 
micrograms of anti-TBP antibody or equivivalent amount of anti-TBP pre-immune serum 
. for 1 hour at 4°C with constant rocking. Protein A agarose beads, 25 microliters, were
12
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added to the above mixture and incubated for 1 hour at 4°C with constant shaking. The 
beads were washed four times with 1 ml of the same buffer to remove unbound proteins 
from the yeast extract, mixed with SDS loading buffer, boiled for 5 min. and separated on 
a SDS-PAGE gel prior to Western analysis. The NOT5 immunoprecipitations were 
conducted in a similar manner 
GST pulldowns
GST fusion proteins were expressed and bound to glutathione-agarose beads as 
described in Chiang et al 1996. Yeast whole cell extracts were prepared from the strain 
yEK20 containing TAFn25-HA13 , in the same buffer used for carrying out the 
immunoprecipitation experiments. Washed gutathione-agarose beads were incubated 
with 2 mg of yeast whole cell extract protein in 250 microliters of Ip/wash buffer for 2 
hours at 4oC on a rocking platform. Unbound proteins were removed by four washes 
with 1 ml of the same buffer and specifically bound proteins were resolved by SDS- 
PAGE after boiling beads directly in sample buffer. Proteins resolved by SDS-PAGE 
were transferred to PVDF membrane and analyzed by Western blotting as described in 
Draper et al 1995. Antibody against SPT3 was provided by F. Winston. TAFn25-HA13 
was detected using the 12CA5 mouse monoclonal anibody against the HA1 epitope.
GST binding
The GST fusion proteins were expressed and purified as described above. The 
binding protocol was similar to the protocol used in the pulldowns, except that, instead of 
yeast extract, the GST fusions were incubated with either 15 microliters of purified 
TFILD or 30 microlitrers of purified SAGA. Antibody to GCN5 was provided by S.
13
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Berger. Purified SAGA was obtained as described in Sterner et al 1999 and purified 
TFnD was obtained as described in Sanders and Weil 1999. The TFI1D was purified to 
near homogeneity and does not contain any contaminating non-TFHD TAFs such as 
MOT1 (Sanders and Weil 1999).The GST fusions were incubated with the purified 
TFED or SAGA complex for one hour at 4°C. Following the washes as described in the 
GST pulldown experiments, the beads were spun down and all the supematent was 
removed. 15 microliters of 5X SDS loading buffer was added to each of the samples and 
boiled for 5minutes.Subsequently the beads were spun down and exactly 15 microliters 
of each sample was loaded on to a pre-cast gradient minigel (4-20%, 0.75mm thick) from 
Biorad. Samples were loaded in alternate wells to prevent crossover spillage into adjacent 
lanes. Subsequently the proteins resolved on the SDS gradient minigel were blotted on to 
PVDF memebrane using a Transblotter from Idea Scientific. Subsequently the membrane 
was incubated in blocking solution containing 10% non-fat milk and .05% Tween 20, for 
one hour. Subsequently the appropriate sections of the membrane were probed with 
primary antibodies against specific components of TFUD or SAGA. The antibodies were 
incubated with the membrane overnight (12-14 hrs) at 4°C. The purified antibodies were 
diluted in solution containing 1% milk and .05% Tween 20 and the crude antisera were 
diluted in solution containing 5% milk and 1% NP40 detergent. Subsequent 
manipulations to visualize the proteins by ECL were carried out as described for the 
immunoprecipitation experiments.
14
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RESULTS
Since the NOT proteins were found to be part of the previously identified CCR4 
complex a detailed phenotypic analysis was carried out to compare the effects of ccr4. 
cafl and various not deletions on expression of specific genes and on diverse cellular 
processes. The results from this analysis are presented in Appendix 1 (Liu et al 1998).
During this phenotypic analysis, it was observed that deletion of CCR4 causes a 
weak but detectable Spt- phenotype (CLD pers. comm.). SPT stands for “Suppression of 
Ty insertion” (Winston 1984). When transposons insert into the promoter of a gene they 
alter the expression of the gene. Ty elements are yeast retrotransposons that insert in and 
out of the genome and affect expression of various genes. Sometimes when Ty elements 
excise they leave behind a copy of their LTR sequence known as the “delta element”. The 
his4-912 delta locus is a specific instance of a “delta” insertion within the HIS4 promoter 
that prevents functional expression of the HIS4 gene. Hence the strains are unable to 
grow on media lacking histidine. As seen from the Figure 2, the presence of the delta 
element causes the HIS4 transcript to initiate within the delta sequence. This results in the 
synthesis of a longer than normal transcript that is non-functional for translation due to 
the presence of stop codons in the 5’ region of this transcript. Mutations that suppress the 
his4-912 delta insertion allow the HIS4 transcript to initiate from its normal start site 
(Amdt et al 1994).
15
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Mutations in several genes involved in transcription have been isolated as suppressors of 
his4-912 delta or other Ty insertions (Winston et al 1984; Winston 1992). These include 
SPT15 which encodes the yeast TBP protein and genes encoding histones. Depending on 
the number and type of Ty insertions suppressed, the SPT genes were classified into the 
‘TBP class” and the “Histone class of SPT genes (Winston 1992)).
16
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912 delta HIS4
Hi. non-consensus TATA
5' CCCTTTTATGGATTCCTA 3' 
3'GGGAAAATACCTAAGGAT5'
Figure 2: Schematic diagram of the his4-912 delta promoter region.
The structure of the his4-912 delta promoter is shown as described in Amdt et al 
1992; 1994. The numerals I, II, DI, IV, indicate the previously described (Amdt et al 
1992) TBP binding sites. Site IV promotes delta expression whereas site I promotes HTS3 
expression. Site m  when mutated interferes with the ability of spt!5-122 to suppress the 
his4-912 delta insertion. The sequence of site HI is shown, with the residues that were 
mutated, indicated in bold letters.
17
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ccr4. cafl. not4 and sptlS-122 suppress his4-912 delta by similar mechanisms
Since ccr4 displayed a weak Spt- phenotype, allowing for growth on media 
lacking histidine, I analyzed the effect of cafl and other not genes on his4-912 delta. I 
found that cafl and not5 also exhibited a weak Spt phenotype while not4 caused a 
moderately strong suppression of his4-912 delta (Table 1). Since NOT1 is essential, I  
looked at the effect of a truncated version of NOT1 on expression from the his4-912 delta 
locus. It was observed that deleting the N-terminal 1300 amino acids of NOT 1 did not 
cause an Spt-phenotype (Table 1) however it caused a dramatic decrease in the frequency 
of Spt-reversion (unpubl. obsv). To determine if the ccr4 and not genes belong to the 
TBP class of SPT genes, I analyzed expression from two other loci containing Ty 
insertions, which are typically suppressed only by mutations in the TBP class of SPT 
genes (Winston 1984; Winston 1992). I found that deleting ccr4 or not4 did not have any 
effect on expression from the his4-917 delta and Ivs2-128 delta insertion loci (data not 
shown), suggesting that ccr4 and not4 did not belong to the ‘TBP class” of SPT genes.
Since the function of the CCR4-NOT complex is thought to be related to the 
function of TBP(Collart 1994; Collart 1996), I further analyzed the Spt- phenotype of 
ccr4 and not4.1 wanted to determine whether the Spt- phenotype of ccr4 and not4 is 
similar to that of sptl5 (TBP).
spt!5-122 is a mutant allele of TBP (L205F) that suppresses his4-912 delta (Amdt 
et al 1994). Residue 205 is known to contact the TATA box and this mutated allele of 
TBP shows increased affinity for binding the non-consensus TATA sequence
18
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TABLE 1
Ability of different mutations in the CCR4-NOT genes to suppress 




CATAA* in his4- 
912 delta










Growth was detected on minimal media lacking histidine. The “ * ” indicates that the 
CATAA sequence at position HI within the delta element has been mutated. The spt6 
data is from F. Winston, pers. comm.
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“CATAAA”. The ability of spt!5-122 to suppress the his4-912 delta insertion depends on 
the “CATAAA” sequence at position IE  (see fig 2) within the “delta” element (Amdt et 
al 1994).
To further analyze the Spt- phenotype of ccr4 , cafl and not4. we investigated the 
ability of ccr4. cafl and not4 to suppress his4-912 delta in a strain wherein the CAT AAA 
sequence at position In within the “delta” element had been mutated. We found that ccr4. 
cafl and not4 were unable to suppress his4-912 delta in this strain (Table 1). In contrast 
spt6 and spt 10. which are not part of the CCR4-NOT complex and are not functionally 
related to TBP (Bortvin et al 1996; Dollard et al 1994), suppressed his4-912 delta 
insertion even when the CATAAA sequence was mutated (Table 1 and F.Winston pers. 
comm.). This data suggested that the Spt- phenotype of ccr4. cafl and not4 was 
mechanistically similar to the Spt- phenotype of spt 15-122.
The model proposed for the mechanism by which spt 15-122 suppresses his4-912 
delta is that, the binding of TBP to the CATAAA sequence at position IE, interferes with 
transcription from the “ TATAA” at position IV within the delta element, thereby 
allowing increased transcription from the HIS4 TATAA (see Figure 2 and Amdt 1994). 
Our data, taken together with the above model suggests that ccr4. cafl and not4 
mutations allow increased binding of TBP to CATAAA which is a non-consensus TATA 
sequence. This is in agreement with previously published data that the NOT proteins 
function to negatively regulate HIS3 transcription from the “Tc element” which is a non­
consensus TATA element (Collart 1996).
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As stated earlier spt 15-122 has greater affinity for CATAAA. as compared to wild 
type TBP (Amdt et al 1994). It has also been shown that spt 15-122 enables increased 
transcription from promoters wherein the TAT AAA sequence has been replaced by 
CATAAA (Amdt 1994)). This analysis was done in strains wherein the Tc and TR 
elements in the HIS 3 promoter were replaced by an oligonucleotide positioned 23 bp 
downstream from the GCN4 binding site (see fig. 1). The oligonucleotides were either 
TAT AAA or derivatives of this sequence containing single base changes (Amdt et al 
1994; Harbury et al 1989).Thus spt!5-122 has been shown to cause increased 
transcription from his3-202 which is the HIS3 promoter derivative containing the 
CATAAA sequence instead of TAT AAA.
The next question I investigated was whether ccr4 and not4 had any affect on 
transcription from his3-202 (CATAAA). This analysis was done using 3-aminotriazole. It 
has been known for several years that the level of HIS 3 transcription can be assayed 
semi-quantitatively by the degree of resistance to 3-amino triazole (3-AT), which is a 
competitive inhibitor of the HIS3 gene product (Klopotowski et al 1965; Struhl 1977). 
Thus a strain containing his3-202 and wild type TBP is unable to grow well on 5mM 3- 
AT and produces low levels of HIS3 mRNA, whereas the same strain with an spt!5-122 
mutation produces much higher levels of HIS3 mRNA (Amdt et al 1994).
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I made ccr4 , cafl. not4 and not5 deletions in the his3-202 strains and analyzed 
the ability to grow on media containing varying concentrations of 3-AT. As seen from 
Table 2, ccr4 and cafl do not have any affect at this promoter where as not4 and not5 
deletions allow growth on 20mM 3-AT, indicating that not4 and not5 deletions allow 
increased transcription from the CATAAA sequence. ccr4 and cafl deletions may not 
show an effect at this promoter since they in general display less repressive effects than 
not4 or not5 (Liu et al 1998).
22
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TABLE 2
Effect of different mutations in the CCR4-NOT 
factors on his3-202 ( CATAAA) expression
Genotype 5mM 3AT lOmM 3AT 20mM 3 AT
wild type w - -
cafl w - -
ccr4 w - -
not4 ++ + +
not5 ++ + +
Growth was detected on minimal media lacking histidine and supplemented with varying 
concentrations of 3-AT as indicated in the Table. All strains are isogenic to FY664 (wild 
type) except for the indicated deleted allele. ++ - strong growth; + - good growth;
w -  weak growth; ~ - no growth.
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not4 and notS deletions increase transcription from non-consensus TATA elements 
irrespective of sequence
Although spt!5-122 and not4 and not5 have the same effect on the his3-202 
promoter, it should be noted that spt!5-122 is a point mutation in TBP that alters its 
binding specificity and increases its binding affinity for the CATAAA sequence. 
Therefore the effect of spt 15-122 is specific to his3-202 and does not affect certain HIS3 
promoter derivatives containing other substitutions in the TATAAA sequence (Amdt et 
al 1994).
The next question I asked was whether spt!5-122 and not4 and not5 affected 
his3-202 (CATAAA) by similar mechanisms. This question was investigated using two 
approaches -
i) If not4 and not5 do not alter the binding specificity of TBP, then their effects 
should not be limited to one particular non-consensus TATAAA element. To test this 
possibility, I made not4 and not5 deletions in strains containing other HIS 3 promoter 
derivatives. As seen in Table 3, I found that not4 and not5 deletions allowed increased 
HI S3 transcription from several different non-consensus TATA elements which were not 
affected by spt!5-122.
ii) If mutations in TBP and NOT4 affected non-consensus TATA elements by the 
same mechanism, then combining these mutations should not have any significant 
additive effects.
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TACAAA ( his3-2«8f 
5mM lOmM
TGTAAA r his3-205) 
5mM lOmM
wild-type -/+
not4 ++ + + + +
HQtS ++ + + + + m













The series of HIS3 genes containing a single TATAAA-like element are all isogenic as described in Arndt et al 1994. 
The sptl5-301 (L114F) allele has been previously shown to confer 3-AT resistance in strains containing the his3-217 




Effect of not4 and sptlS-301 alleles on his3-217 (TATAAG) expression
Genotype 20mM 3AT 40mM 3AT 80mM 3AT
wild type - - -







Growth was monitored on minimal media lacking histidine supplemented with 3-AT 
at the concentrations indicated. All the strains are isogenic to FY676 (wild type)
except for the indicated alleles. ++ - strong growth; + - good growth; ~ - no growth.
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It should be noted that, for reasons unrelated to HIS3 transcription strains containing 
spt!5-122 mutations are very sensitive to 3-AT and hence could not be used for this 
analysis (Amdt et al 1994). Therefore we used sptl 5-301 (LI 14F) which is another 
point mutation in TBP that increases its affinity for the sequence TATAAG and thus 
allows increased transcription from his3-217 (TATAAG) (see Table 4 and Amdt 
1994)
Thus as seen in Table 4, while not4 and sptl 5-301 mutations allow growth on 
20mM and 40mM 3-AT respectively, in combination they allow growth on 80mM 3- 
AT. Thus the additive effect of these two mutations on transcription from his3-217 
(TATAAG) suggests that they function by different mechanisms.
It should be noted that although certain combinations of not gene deletions 
display enhanced effects on growth, they do not have additive effects on HIS3 
transcription (Collart 1994). However, I was unable to determine the effect of 
combining not4 and not5 deletions on his3-202 transcription, since combining these 
two deletions is synthetically lethal (Oberholzer 1998).
Taken together these data indicate that while TBP mutations alter its^binding 
specificity and cause increased transcription from certain specific non-consensus 
TATA elements, the not4 and not5 mutations allow increased transcription from all 
non-consensus TATA elements tested. The not4 and not5 mutations appear to 
stabilize TBP-TATA box interactions irrespective of the sequence and by a 
mechanism that is apparently different from augmenting the affinity of TBP binding 
to a particular non-canonical TATA sequence.
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As seen above, point mutations in the TATA element reduce the level of 
expression due to reduced stability of binding of TBP to these TATA elements. It was 
possible that increasing the concentration of TBP in the cell would shift the balance 
of the TBP-DNA binding equilibrium towards the bound form, thereby increasing the 
stability of this TBP-DNA interaction and allowing increased expression from the 
mutant TATA elements. To test this possibility, I overexpressed TBP in strains 
containing the his3-202 (CATAA) promoter derivative and found that it did not cause 
any increase in the level of HIS3 expression (data not shown). These results suggest 
that factors other than TBP are limiting or essential for transcription from non­
consensus TATA elements. These other factors are likely to be proteins that associate 
with TBP and modulate its function at a subset of promoters. Such a group of proteins 
include the TAFs, ITUA and SPT3, SPT8. Based on the above genetic analysis, it can 
be hypothesized that the CCR4-NOT complex affects TBP activity by binding and 
modulating the activities of one or more of these proteins. I investigated this 
possibility using a genetic strategy involving analysis of dosage effects and 
suppressors.
Dosage-dependent interactions between NOTs, TBP and TAFs
The above data implicate a balance between the CCR4-NOT complex and 
TBP and its associated factors in regulating gene expression. The effect of increasing 
the levels of CCR4-NOT protein components in combination with the TBP allele 
spt 15-122 was subsequently investigated. Increasing the dosage of NOT1 was found 
to specifically inhibit the Spt- phenotype of spt 15-122 (Table 5) but did not affect the
29
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Spt- phenotype of spt 10 and spt3 mutations (data not shown). Elevated expression of 
NOT2 or NOT4 did not have any effect in the sp tl5-122 strain while increasing the 
dosage o f NOT3 caused a weak inhibition of the Spt- phenotype (Table 5). I also 
analyzed the effects of overexpression of TAFs in combination with not defects. I 
found that overexpression of TAFn19 in a not3-2 strain and in a not5 deletion strain 
caused extremely slow growth at 30°C and also caused synthetic lethality at 34°C in 
the not5 strain (Table 6). This is a specific effect since overexpression of several 
other TAFs such as TAFn130, TAFn67, TAF^O, did not have any effect on the 
growth o f not3-2 and not5 strains. Also, overexpression of TAFn19 did not have any 
effect in not 1-2. not2. not4. or cafl strain backgrounds (data not shown). These 
results indicate that the CCR4-NOT complex and TBP as well as the TAFs 
functionally interact with each other and that altering the balance between these two 
groups of proteins can result in severe growth and transcriptional defects.
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TABLES
Effect of increased concentration of different NOT proteins
on the ability of spt!5-122 to suppress the his4-912 delta insertion
Increased dosage of







Growth was monitored on minimal media lacking histidine and uracil. The strain 
FY475 (spt!5-122>) was transformed with pRS316 derivatives containing NOT1. 
NQT2. NOT3. and NQT4 genes, respectively, under the control of their respective 
native promoters.
+ - good growth; w -  weak growth; - no growth.
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TABLE 6
Effect of TAFn 19 overexpression on growth of not3-2 and not5 alleles
PLASMID Wt not3-2 not5
30°C 34°C 30°C 34°C 30°C 34°C
YEp24 + + + + + +
TAF19 + + w/- w/- w/- -
TAF40 + + + + + +
TAF60 + + + + + +
TAF67 + + + + + +
TAF130 + + + + + +
Growth was detected on SC plates lacking uracil, to maintain selection for the TAFn 
plasmids. not5 (MY1735-1), not3-2 (MY25), wild type (KY803).
+ - growth; w/- - very weak growth;_ - no growth. All TAFn plasmids are 2 micron 
plasmids.
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spt3. spt8 and spt!5-21 mutations suppress ccr4 and cafl deletions.
The above genetic experiments indicate that components of the CCR4-NOT 
complex can functionally interact with TBP and its associated factors. Although it is 
clear from these above experiments that the NOTs appear more closely aligned with 
TBP and its associated factors than CCR4 and CAF1, ccr4 and cafl do display some 
genetic interaction with TBP as evidenced from the similar behavior to spt 15-122 in 
terms of suppressing his4-912 delta. Part of this difference between CCR4 and CAF1 
and the other NOT proteins may be their physical location in the CCR4-NOT 
complex. The not 1-2 allele has been found to specifically retain the ability to interact 
with CCR4 and CAF1 and is most likely deficient in interacting with NOTs 2 ,4 , and 
5 (Bai et al 1999). Since it has been shown that the temperature sensitive phenotype 
associated with the not 1-2 allele is specifically suppressed by spt3 and spt8 deletions 
(Collart 1996), we therefore investigated the effect of spt3 and spt8 defects on ccr4 
and cafl phenotypes. An spt3 deletion suppressed the caffeine sensitivity and cold 
sensitivity of a ccr4 deletion or a cafl deletion but did not suppress the glycerol 
temperature sensitivity phenotype (Table 7 and data not shown)
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TABLE 7
spt3 , spt8 and sptl5-21 suppress ccr4 and cafl defects
genotype 8mM Caffeine 13°C
wt + +
ccr4 - -
ccr4 sDt3a + +
ccr4 spt8b + +
ccr4 sptl5-21c + +
cafl - -
cafl spt3d + +
snt8e + +
Growth was detected on YEP plates containing 2% glucose and supplemented with 8 
mM caffeine as indicated in the Table, wt ( DY3462), ccr4 ( 612-ld-2A), cafl ( 
DY3462-cl)
a Isogenic to 612-ld-2A except for the indicated deletion allele 
b Analyzed four segregants of cross DY3462-4 and FY50 
c Analyzed four segregants of cross DY3462-4 and L886 
d Analyzed four segregants of the cross DY3462-cl and FY464 
e Analyzed four segrgants from cross DY3462-4 and FY50
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An spt8 deletion also suppressed ccr4 and cafl defects (Table 7 ). Using an sptl 5-21 
allele that results in a TBP that is specifically defective in binding SPT3 (Eisenmann 
et al 1992), we examined whether the ability of spt3 to suppress ccr4 was related to 
the ability of SPT3 to bind TBP. The spt 15-21 allele also suppressed defects caused 
by a ccr4 deletion (Table 7). An spt7 deletion did not have any affect on ccr4 and 
cafl phenotypes. These results confirm that CCR4 and CAF1 also functionally 
interact with TBP and SPT3 and indicate that different components of the CCR4- 
NOT complex display different genetic interactions with TBP and its associated 
factors.
Overexpression of NOT1 suppressed the his4-912 delta Insertion in CATAAA 
dependent manner
It was observed that overexpressing NOT1 from a high copy vector caused an 
Spt- phenotype at the his4-912 delta locus (Table 8). This effect was specific to 
NOT1 since overexpression of other NOTs or CCR4 did not cause an Spt- phenotype. 
This phenotype is not elicited by increasing the dosage of NOT1 using a low-copy 
centromeric vector (Table 8). Upon further analysis it was found that the ability of 
high copy NOT1 to suppress the his4-912 delta insertion was dependent on the 
presence of the CATAA sequence at position In within the his4-912 delta promoter 
(Table 8), as previously seen for the not4 and ccr4 Spt- effects (Table 1).
Since increased dosage of NOT1 using a low copy plasmid inhibits the ability 
of spt 15-122 to suppress the his4-912 delta insertion (Table 5), I investigated the 
effect of high copy NOT1 on spt!5-122 phenotypes. Consistent with the above data,
35
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combining high copy NOT1 with spt!5-122 did not inhibit the suppression of his4- 
912 delta (Table 9) 9). In fact it enhanced the Spt- phenotype of spt 15-122 as 
evidenced by the better growth of sptl5-122 on His- galactose media, in the presence 
of high copy NQT1 (Table 9).
Effects of overexpression of CCR4-NOT components on his3-202 expression
Taken together, the dependence of the Spt- phenotype of high copy NQT1 on 
the CATAA sequence within the his4-912 delta promoter and the additive effects of 
NOT1 with spt 15-122 suggest that overexpressing NOT1 allows better binding of 
TBP to the CATAA sequence within the his4-912 delta element by a mechanism 
distinct from that of spt 15-122. Subsequently, I analyzed the effect of overexpressing 
NOT1 on transcription from the his3-202 (CATAA) promoter. It was found that high 
copy NOT1 did not augment expression from the his3-202 promoter (Table 10). 
However, during this analysis I found that overexpressing NOT3 or NOT5 augmented 
HIS3 expression from the his3-202 (CATAA) promoter, while high copy NOT2 or 
CAF1 had no effect (Table 10). This result is similar to the effect of overexpressed 
NOT3 or NOT5 on expression from the native HIS 3 promoter in a strain deleted for 
GCN4 (CLD pers. comm).
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TABLE 8
Effect of overexpression of CCR4-NOT components on his4-912 delta expression








Growth was detected on media lacking histidine. The strain used was DY3462. All 
the NOT genes are expressed from their native promoters on 2 micron plasmids 
containing the URA3 gene. The CCR4 plasmid was obtained by disrupting the LEU2 
gene in the MPT2 plasmid (Sakai) with the URA3 gene.
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TABLE 9
Effect of sptl5-122 and NOT1 overexpression on his4-912 delta expression
Genotype his4-912 delta suppression 
on Glucose
his4-912 delta suppression 
on Galactose
Wild type /  vector — —
Wad type/Ep-NOTl + —
WUd type /  CEN-NOT1 — —
sptl5-122 /  vector + w
sptl5-122/Ep-NO Tl ++ +
Growth was detected on minimal media lacking uracil and histidine containing 
glucose or galactose, as indicated. Wild type (DY3462), sptl5-122 ( FY475). Ep- 
NOT1- NOT1 is expressed from its native promoter on a 2 micron plasmid containing 
the URA3 gene.
CEN-NOT1- Described in Table 5 legend, NOT1 expressed from its native promoter 
on a centromeric plasmid.
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TABLE 10
Effect of overexpression of CCR4-NOT components on expression from non­
consensus TATA elements
Plasmid his3-202 CCATAAA'l 1 his3-217 fTATAAG')
5mM lOmM 5mM lOmM
NOT1 w _ ND ND
NOT2 w _ ND ND
NOT3 + + + ++ +
NOT5 + + + ++ +
CAF1 w _ w ---
vector w --- w ----
Growth was monitored on m inim al media lacking histidine and supplemented with 3- 
AT at the concentrations indicated. his3-202 (FY664), his3-217 (FY676). All the 
NOT genes are expressed from their native promoters on 2 micron plasmids 
containing the URA3 gene. The CAJF1 plasmid was obtained by disrupting the LEU2 
gene in the MPTO plasmid ( obtained from B. Anderson) with the URA3 gene. ++ - 
Strong growth;
+ - good growth; w -  weak growth; — - no growth; ND -  Not Done.
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NOT2 and NOT5 co-immunoprecipitate with TBP
All of the above described genetic interactions and dosage effects strongly 
support the possibility that the CCR4-NOT complex physically interacts with TBP, 
TAFs or other TBP - associated factors. To initially address this possibility I carried 
out immuno-precipitation experiments using LexA-tagged versions of the NOT 
proteins. It was found that immunoprecipitating TBP with anti-TBP antibody 
specifically brought down LexA-NOT2 and LexA-NOT5 but did not bring down 
LexA alone (Figure 3A, lanes 7-8 as compared to lane 6). As an additional control, I 
showed that TBP pre-immune serum did not immunoprecipitate LexA-NOT2 (Figure 
3A, lane 5). Immunoprecipitating TBP did not bring down LexA-CCR4, LexA-CAFl 
or LexA-NOT4 ( data not shown), indicating on the one hand that the LexA-NOT2 
and Lex-NOT5 interaction with TBP was not due to the LexA moiety and, on the 
other hand, that NOT2 and NOT5 are more closely associated with TBP and its 
associated factors than other components of the CCR4-NOT complex.
Subsequently, it was found that immunoprecipitating TBP brought down the 
endogenous NOT2 (Figure 3B, lane 2), confirming that the interactions between TBP 
and NOT2 and NOT5 were not dependent on the presence of the LexA moiety. Anti- 
TBP pre-immune serum did not co-immunoprecipitate NOT2 (Figure 3B, lane 3). 
These data agree with recent studies indicating that NOT1 can physically associate 
with TBP (Lee et al 1998) and that NOT2 and NOT5 are closely associated with each 
other and somewhat separately from CCR4 and CAF1 in the CCR4-NOT complex 
(Bai et al 1999). The above observations also suggest that the immunoprecipitations
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are only bringing down subsets of proteins that are associating. In order to examine 
TBP-NOT interactions more fully, the immunoprecipitations were conducted in the 
opposite direction. Immunoprecipitating NOT5 co-immunoprecipitated TBP while 
NOT5 pre-immune serum did not bring down TBP (Figure 4, lane 5 as compared to 
lane 3). Also anti-NOT5 antibody was unable to immunoprecipitate TBP from a not5 
deletion strain (Figure 4, lane 4). These combined data clearly indicate that NOT5 
and NOT2 can associate with TBP in vivo.
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Figure 3A: TBP immunoprecipitates LexA-NOT2 and LexA-NOT5
Yeast extracts from haploid strain EGY188 containing LexA fusion proteins as 
indicated were immunoprecipitated with anti-TBP antibody (lanes 6-8) and with 
preimmune semm (lanes 4-5). LexA fusion proteins were detected by western 
analysis following SDS-PAGE using LexA antibody. LexA-NOT2 (lanes 2, 5, 7), 
LexA-NOT5 (lanes 3, 8), and LexA Qanes 1,4, 6) contained full-length NOT2, 
NOT5, and LexA respectively. Crude extracts are represented in lanes 1-3. 10 
microliters of whole cell extract was loaded as crude extract and 250 microliters of 
extract was used for each immunoprecipitation reaction.
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Crude TBP Ip Preimmune
NOT2
Figure 3B: TBP immunoprecipitates the endogenous NOT2 protein
Yeast extracts from strain EGY188 were immunoprecipitated with anti-TBP 
and preimmune serum as described in Figure 3 A. NOT2 protein was detected by 
western analysis following SDS-PAGE using NOT2 antibody. Lane 1 represents the 
crude extract, lane 2 represents the anti-TBP immunoprecipitate and lane 3 represents 
the immunoprecipitate of the preimmune serum.
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Pre-
Cr. Extract Immune N0T5 Ip
NOT5
Figure 4: NOT5 immunoprecipitates TBP
Immunoprecipitations using NOT5 antiserum and preimmune serum were conducted 
as described in Figure 3. Lanes 1-2 represent crude extracts, lane 3 represents the 
preimmune serum immunoprecipitate, lanes 4-5 represent the anti-NOT5 
immunoprecipitates. NOT5 - strain KY803; not5 - strain MY1735.
44
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Cr. Extract N0T5 Ip





Figure 5A: NOT5 immunoprecipitates TAFn90.
Immunoprecipitations using N0T5 antiserum and subsequent analysis were 
performed as described in Figure 4. NOT5 immunoprecipitates TAFn90. Lanes 1 and 
2, Crude extract.Lanes 3 and 4, NOT5 immunoprecipitations.Lanes 2 ,4  - Strain 
KY803. Lanes 1 ,3 -  Strain MY1735. Western analysis was done with anti-TAFn90 
and TBP antiserum. IgG is also indicated.
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Figure 5B: NOT5 immunoprecipitates TAFn130.
Immunoprecipitations using NOT5 antiserum and subsequent analysis were 
performed as described in Figure 4. NOT5 immunoprecipitates TAFn130. The arrow 
indicates the position of the full length TAFn130 protein and the band below that is 
presumed to be TAFn130 degradation product. Lane designations are same as in “5A” 
above. NOT5 - strain KY803; notS - strain MY1735.
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NOT2 and NOT5 associate with several TAFs
Since TBP co-immunoprecipitated with NOT5,1 subsequently probed for the 
presence of TAFs in the NOT5 immunoprecipitate. It was found that both TAFn90 
and TAFn130 specifically co-immunoprecipitated with anti-NOT5 antibody from a 
wild type strain but not from a strain deleted for NOT5 (Figure 5A and 5B, lanes 3 
and 4 respectively). It should be mentioned that, in contrast to the above results, 
immunoprecipitating CCR4 did not bring down TBP or TAFn90 (Komamitsky et al 
1998; data not shown). This result is expected since anti-CCR4 antibody appears to 
only immunoprecipitate the CCR4-NOT complex (Draper et al 1994; Liu et al 1998; 
unpubl. observe.) and LexA-CCR4 was not immunoprecipitated with anti-TBP 
antibody. It should be noted that some of the other TAFns (such as TAFn61 and 
TAFn60) non-specifically immunoprecipitate with the anti-NOT5 antibody (data not 
shown) and therefore their specific immunoprecipitation with NOT5 could not be 
determined.
To analyze these interactions from another direction I analyzed the association 
of TBP and its associated factors with the CCR4-NOT complex protein components 
using GST-NOT2 and GST-NOT5 proteins that were expressed and purified from E. 
coli (see Figure 6B for the relative levels of GST-NOT2 and GST-NOT5 and the 
controls GST and GST-Vpu used in these experiments). When whole cell extracts 
from wild type yeast strains were passed over these GST fusions, GST-NOT2 
specifically retained TAFn90, TAFn61, TAFn25-HA and TBP while the control GST 
fusions did not retain any of the above mentioned proteins (Figure 6A, lane 3 as
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compared to lanes 2 and 4). Since the TAFs specifically retained by GST-NOT2 are 
also components of the SAGA complex I probed for SPT3 which is present only in 
the SAGA complex but is not a  component of TFECD. It was found that SPT3 was 
also specifically retained by GST-NOT2 (Figure 6A, lane 3). In similar experiments 
GST-NOT5 retained TAFn90, TAFn61, TAF[j40, TBP (Figure 7A, lane 3) and SPT3 
(Figure 7B lane3).
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Figure 6A: GST-NOT2 retains TBP, SPT3, and several TAF„s.
GST fusions were induced as described (Chiang et al 1996), bound to 
glutathione agarose beads, and incubated with yeast crude extract from the strain 
yEK20 containing TAFn25-HA13 as described in “Materials and Methods”. Proteins 
were eluted from glutathione-agarose beads by boiling and separated by SDS-PAGE. 
Western analysis was conducted by probing with appropriate antibodies. TAFn25- 
HA13 was detected using the 12CA5 mouse monoclonal antibody against the HA1 
epitope.Lane 1- crude extract; lane 2 - GST; lane 3 - GST-NOT2; lane 4 - GST-Vpu. 
The lane 1 SPT3 band is indicated with an arrow.
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Figure 6B: Coomassie Blue stained gel showing expression levels of GST-fusions
Protein levels of the GST fusions used in Figure 6A and 7, as determined by 
Coomassie Blue staining. The bands beneath GST-NOT5 (arrow) are apparent 
degradation products as determined by Western analysis.
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Figure 7: GST-NOT5 retains TBP, SPT3, and several TAFns.
GST pulldown experiments were performed as described in Figure 
6A. Lane 1 - crude extract; lane 2 - GST; lane 3 - GST-NOT5; lane 4 - GST-Vpu.
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Figure 8: Binding of purified TFIID with GST-NOT5 and GST-NOT2
The GST fusions were incubated with 15 microliters of purified TFDD for one hour at 
4  oC. Further manipulations were carried out as described in Figure 6A. Lane 1- 
Input, 5 microliters of TF11D; Lane 2- GST-Vpu; Lane 3- GST-N0T5; Lane 4- GST- 
NOT2. TAFu40 and TAFn19 antibodies were not used to probe the interactions of 
GST-NOT2 with purified TFDD.
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Figure 9: Binding of purified SAGA with GST-NOT2 and GST-NOT5
The binding was carried out as described in Sterner et al 1999. The GST 
fusions were incubated with 30 microliters of purified SAGA. Further manipulations 
were carried out as described in Figure 6A. Lanel- Input, 10 microliters of SAGA; 
Lane 2- GST; Lane 3- GST-NOT2; Lane 4- GST-NOT5.
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NOT5 and NOT2 retain multiple components from purified TFDD and SAGA, 
respectively
The above results indicated that NOT2 and NOT5 could associate with several 
proteins that were components of TFLLD and SAGA or both. To further dissect these 
interactions I carried out binding experiments using purified TFUD and purified 
SAGA complexes. It was found that GST-NOT2 did not retain any of the proteins 
tested from purified TFIID (Figure 8 lane4). In contrast GST-NOT5 retained 
TAFn130, TAFn61, TAFn60, TBP and TAFn19 from purified TFUD but TAFn90 and 
TAFn40 ,were not retained by GST-NOT5 (Figure 8 lane3). In similar experiments 
with purified SAGA I found that GST-NOT5 did not retain any of the proteins tested 
(Figure 9 lane4) while GST-NOT2 retained TAFn90 and TAFn61 but TAFn60 was 
not retained by GST-NOT2 (Figure 9 lane 3).
Genetic and biochemical interaction between TEHA and the CCR4-NOT 
complex
It has been shown that overexpression of TBP specifically enhances 
transcription from consensus TATA elements but not from non-consensus TATA 
elements (Colgan et al 1992; Collart 1996). This indicates that one or more factor(s) 
other than TBP are important for transcription from non-consensus TATA elements.
It is possible that the NOT proteins function by blocking access of these factor(s) to 
the promoter or by inhibiting the function of these factor(s). Based on this hypothesis 
it should be possible to overcome the repressive effects of the NOTs by increasing the 
concentration of these factor(s).
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Since TAFs, TFDA and SPT3 are factors that associate with and modulate 
TBP function positively, one or more of these factors could potentially be required for 
optimal function of TBP at non-consensus TATA elements. I analyzed if 
overexpression of any of these proteins augmented expression from the his3-202 
(CATAA) promoter (data not shown). Among all the proteins analyzed, only 
overexpression of TFUA caused increased expression from the his3-202 (CATAA). 
TFELA consists of two subunits TOA1 and TOA2. Overexpression of each subunit 
individually did not affect expression from the his3-202 promoter (Table 11). This 
suggests the the effect is dependent on the function of TFUA and is not due to 
titration of any factor that binds one of the subunits of TFDA. Subsequently I found 
that overexpression of TFUA augmented expression from his3-217 (TATAAG)
(Table 11) and his3-216 (TATAAT), indicating that increasing the levels of TFDA 
increases expression from several different non-consensus TATA elements 
irrespective of their sequence. This was similar to what was observed when not4 and 
not5 deletions were tested (Table 2 and 3).
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TABLE 11
Effect of overexpressing TFUA subunits on different his3 promoter alleles






TOA1+ TOA2 + +
TOAl(Y69A) + TOA2 — —
TOA1 — ND
TOA2 — ND
Growth was monitored on media lacking histidine supplemented with 3-AT at the 
concentrations indicated. his3-202 (FY664), his3-217 (FY676). The TFIIA plasmid 
expresses both subunits of TFUA and has been described in Madison andWinston 
1998.
TOA1 and TOA2 genes are expressed from their native promoters on 2 micron 
plasmids containing the LEU2 and URA3 genes, respectively.
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Subsequently, I investigated whether deletion of not4 and overexpression of TFIIA 
augmented expression from non-consensus promoters by affecting the same step in 
transcription initiation at these promoters. I overexpressed TFIIA in strains deleted 
for not4 and containing the his3-202 allele and found that there was no additive 
increase in expression from the his3-202 promoter (Table 12). Similar results were 
obtained when TFDA was combined with a not5 deletion (Table 12). This data 
suggested that overexpression of TFUA and deletion of not4 or not5 augmented 
expression from non-consensus TATA elements by affecting the same step in 
transcription initiation at these promoters. Presumably this step involves the 
functional interaction between TBP and TFIIA. Subsequently I analyzed if TBP- 
TFliA interactions were important for the effects of TFDA on expression from the 
non-consensus TATA elements. This analysis was performed using a mutant allele of 
the TOA2 containing the Y69A substitution. This particular allele is defective for 
interaction between TFUA and TBP and has been shown to reduce expression of 
several genes, including HIS3 (Ozer et al 1998). In contrast to the wild type subunits, 
the Y69A allele of TOA2, when overexpressed in combination with TOA1, did not 
augment expression from the his3-202 (CATAA) promoter (Table 11).Therefore the 
ability of high copy TFIIA to increase expression from non-consensus TATA 
elements requires functional interaction between TFIIA and TBP.
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TABLE 12
Effect of TFIIA and not deletion on expression from his3-202 (CATAAA)
Genotype 10 mM 20 mM 40 mM
Wild type/TFUA + + __
not4 ++ + w
not4 / TFIIA ++ + w
notS ++ + w
not5 / lF ilA ++ + w
Growth was monitored on minimal media lacking histidine supplemented with 3-AT 
at the concentrations indicated. Wild type (his3-202, FY664). All strains are isogenic 
derivatives of FY664. The TFIIA plasmid expresses both subunits of TFDA and has 
been described in Madison andWinston 1998.
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TABLE 13A
Effect of combining not4 deletion with overexpression of TOA alleles on his3-202
(CATAAA) expression
Genotype 5 mM 10 mM 20 mM 40 mM
not4 /  vector ++ ++ + w
not4 /  TOA1 ++ ++ + w
not4 /  Y69A + w ---- ----
Growth was monitored on media lacking histidine supplemented with 3-AT at the 
concentrations indicated. not4 (FY664-n4). TOA1 alleles are expressed from their 
native promoters on 2 micron plasmids containing the LEU2 gene. Vector (YEpl3)
TABLE 13B
Effect of TOAl(Y69A) overexpression on expression from his3-202 (CATAAA)
Genotype 2 mM 5 mM
W t/vector + w
W t/T O A l + w
Wt /  Y69A w ----
Growth was monitored on media lacking histidine supplemented with 3-AT at the 
concentrations indicated. Wt (his3-202, FY664).
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Thereafter I investigated the role of TBP-TFDA interactions in the effects of 
not deletions on expression from the non-consensus TATA elements. I found that 
overexpressing the Y69A allele of TOA2 reduced expression significantly from the 
his3-202 promoter in a not4 deletion strain (Table 13A). This indicated that the Y69A 
allele of TOA2 had a dominant negative effect by replacing the wild type TOA2 
subunit in the TFUA dimer, thereby disrupting TBP- iT ilA  interactions. The 
reduction in his3-202 expression suggests that functional TFHA-TBP interactions are 
required for the not4 deletion mediated effects on expression from non-consensus 
TATA elements. However high level expression of the Y69A allele of TOA2 was 
found to cause a further decrease in the low level expression from the his3-202 
(CATAA) promoter in the wild type strain (Table 13B). This result raises the 
possibility that the TFUA functions downstream of the NOTs and that TFDA is not 
directly involved in the mechanism of action of the CCR4-NOT complex.
A biochemical approach was taken to further explore the possible role of 
TFDA in the functioning of the CCR4-NOT complex. This work was carried out in 
collaboration with Y-C. Chiang a research scientist in our lab. Using the type of 
immunoprecipitation experiments previously described, it was found that 
immunoprecipitating LexA-NOT2 or LexA-NOT5 specifically coimmunoprecipitated 
TOA2, while neither the control LexA-Vpu nor the LexA moiety by itself co- 
immunoprecipitated TOA2 (Figure 10). TOA1 could not be detected due to the high 
background signal from the rabbit IgG which migrates at the same position as TOA1. 
TOA2 was also found to specifically co-immunoprecipitate with the endogenous
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NOT5 protein, when immunoprecipitated using anti-NOT5 antibody (Figure 11). In
contrast, immunoprecipitating CCR4 did not co-immunoprecipitates TO A2 .
These results indicated a physical interaction between NOT5 and TFHA. The 
interaction between TBP and TFLLA is well documented and I had observed a 
physical association between TBP and NOT5 as well as NOT2. To further dissect 
these interactions we utilized the previously described Y69A allele of TOA2. TBP 
immunoprecipitations were carried out from a strain containing only the Y69A allele 
of TOA2 and from the isogenic wild type strain. It was found that, while TBP could 
co-immunoprecipitate TOA2 from the wild type strain, no interaction between TBP 
and TOA2 was detected in the Y69A strain (Figure 12, lane 3 vs 4). In similar 
immunoprecipitation experiments using antibody against NOT5, it was observed that 
NOT5 could co-immunoprecipitate TBP and TOA2 from the wild type as well as 
from the Y69A strain (Figure 13, lanes 3 and 4). Taken together these results indicate 
that the interaction between NOT5 and TBP is not mediated by TFIIA. Moreover, 
these results imply that the TBP-NOT5 and the TFHA-NOT5 interactions occur 
independent of each other.
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Figure 10: LexA-NOT2 and LexA-NOT5 immunoprecipitate TFI1A
Yeast extracts from haploid strain EGY188 containing LexA fusion proteins 
as indicated were immunoprecipitated with anti-LexA antibody (lanes 5-8). LexA 
fusion proteins were detected by western analysis following SDS-PAGE using LexA 
antibody. LexA-NOT2 (lanes 3, 7), LexA-NOT5 (lanes 4, 8), LexA (lanes 1, 5) and 
LexA-Vpu (lanes 2, 6) contained full-length NOT2, NOT5, LexA and LexA-Vpu 
respectively. Crude extracts are represented in lanes 1-4. 10 microliters of whole cell 
extract was loaded as crude extract and 250 microliters of extract was used for each 
immunoprecipitation reaction.
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Figure 11: NOT5 immunoprecipitates TFIIA
Immunoprecipitations using NOT5 antiserum and preimmune serum were 
conducted as described in Figure 4. Lanes 1-2 represent crude extracts, lane 3 
represents the preimmune serum immunoprecipitate, lanes 4-5 represent the anti- 
NOT5 immunoprecipitates. NOT5 - strain KY803; not5 - strain MY1735.
65







Figure 12: TBP does not immunoprecipitate TFIIA from the TOA2 (Y69A) 
strain
TBP immunoprecipitations were carried out as described in Figure 3. The 
immunoprecipitations were carried out using extracts prepared from strains Y61 (Wt) 
and Y69 (toa2-Y69A). Lanes 1-2 represent crude extracts, lanes 3-4 represent the 
anti-TBP immunoprecipitates.
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Figure 13: NOT5 immunoprecipitates TBP and TFUA from 
the TOA2 (Y69A) strain
Immunoprecipitations using NOT5 antiserum were conducted as described in 
Figure 4. The immunoprecipitations were carried out using extracts prepared from 
strains Y61 (Wt) and Y69 (toa2-Y69A). Lanes 1-2 represent crude extracts, lanes 3-4 
represent the anti-NOT5 immunoprecipitates.
67
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
DISCUSSION
Functional interaction between the CCR4-NOT complex with TBP and 
associated factors
These studies have demonstrated the functional and physical interactions 
between the CCR4-NOT complex and that of TBP and its associated factors . The 
functional interaction between TBP and the CCR4-NOT complex is based on four 
lines of evidence. Firstly, mutations in CCR4. NOT4. and NOT5 suppress the his4- 
912 delta insertion by a mechanism similar to that observed for the mutated TBP 
allele sptl 5-122. This mechanism appears to involve stabilization of TBP binding to 
a specific non-consensus TATA sequence, CATAAA, in the his4-912 delta element. 
Secondly, a specific mutation in TBP (L205F) and deletion of not2. not4. and not5 all 
caused increased transcription from modified HIS 3 promoters containing specific 
non-consensus TATA elements. Thirdly, increased dosage of NOT 1 specifically 
inhibited the ability of sptl 5-122 to suppress the his4-912 delta insertion but did not 
affect the Spt- phenotype of spt3 and sptlO at this locus. Fourthly, spt3, spt8. and 
sptl 5-21 alleles (all involved in affecting interaction of SPT3 with TBP) suppressed 
ccr4 and cafl defects. These results establish a functional relatedness between the 
CCR4-NOT complex and TBP and its associated factors that had only been 
previously suggested (Collart 1996).
It was also shown that the function of CCR4 and CAF1 is closely linked to the 
function of NOT 1, since mutations in all three genes can be suppressed by spt3. spt8
68
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
and by a specific mutation in TBP. sptl 5-21. that blocks TBP-SPT3 interactions 
(Eisenmann 1994). This result indicated that ccr4. cafl and not 1-2 mutations had the 
same effect at certain promoters and that functional interaction between TBP and 
SPT3 is essential for optimal transcription from these promoters. These results also 
confirm the previous close physical and functional association between CCR4, CAF1 
and the NOT1 proteins (Draper et al 1995;Liu et al 1998; Bai et al 1999). 
ccr4. ca fl. not4. and  sntlS-122 suppress his4-912 delta expression by sim ilar 
mechanisms
It was demonstrated that mutations in certain components of the CCR4-NOT 
complex cause suppression of the his4-912 delta insertion by a mechanism similar to 
that proposed for sp tl5-122. The model proposed for the mechanism by which sp tl5- 
122 suppresses his4-912 delta is that the binding of TBP to the CAT AAA sequence at 
position In interferes with transcription from the " TATAA" at position IV within the 
delta element, thereby allowing increased transcription from the HIS4 TATAA (see 
Figure 2) (Arndt et al 1994). Our data, taken together with the above model suggests 
that ccr4. cafl. and not4 mutations also allow increased binding of TBP to CAT AAA, 
a non-consensus TATA sequence. This model is consistent with the previously 
proposed role of NOT proteins in repressing the non-consensus TATA element, Tc, 
dependent transcription from the HIS3 promoter (Collart 1996).
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Mutations in NOT genes cause increased transcription from non-consensus 
TATA elements irrespective of the sequence
Subsequently it was found that mutations in the not genes allow increased 
transcription from several different "mutant" TATA sequences which could be 
classified as non-consensus TATA elements. The unique and distinguishing feature of 
this analysis is that it was carried out in strains in which the HIS 3 promoter was 
modified such that it contained only one TATA element, expression from which was 
activated by a wild-type allele of GCN4. The results from these studies indicate that 
the function of the NOT proteins is not specific to the Tc element. Rather, the NOT 
proteins are general repressors of TBP function, irrespective of the DNA sequence 
bound by TBP. This model is also consistent with the role of the NOT proteins as 
global repressors of transcription, as inferred from the fact that mutations in CAF1 
and NOT genes can suppress mutations in SRB4 and RPB1. both of which are 
essential for global mRNA synthesis (Lee et al 
1998).
However, the mechanism by which not alleles allow increased transcription 
from these non-consensus TATA sequences appears different than altering the 
binding per se of TBP to the ‘TATA’- like sequences. This is suggested by two 
observations. First, the expression from several different ‘ TATA’- like sequences 
was augmented by not alleles. In contrast, TBP alterations such as L205F or L I 14F 
tend to only affect expression from one or another ‘ TATA’-like sequence (Arndt et 
al 1994). Therefore, it is unlikely that the not deletions result in altered binding
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specificity of TBP. Second, a not4 deletion caused increased 3-AT resistance even in 
a TBP (LI 14F) background, suggesting that the not effect occurred by a mechanism 
separate from that of L I 14F effects on the DNA binding specificity of TBP. 
Mechanism of action of CCR4-NOT complex in affecting TBP function
The genetic analysis described above and previous data (Collart and Struhl 
1993, 1994; Oberholzer et al 1998), support the model that the NOT proteins exert 
their repressive effects by destabilizing functional interaction of TBP with DNA. The 
NOT proteins could accomplish this by several possible mechanisms. 1) The NOT 
proteins could directly bind TBP and inhibit its ability to bind DNA. This possibility 
seems unlikely in that, as described above, the not alleles affected functional TBP 
binding to a variety of non-consensus TATA sequences and by a mechanism that is 
apparently separate from TBP binding to DNA. This model is also inconsistent with 
the fact that overexpression of TBP did not overcome the repressive effects of the 
NOTs at the modified HIS3 promoters used in these studies (unpub. observe.). This 
implies that TBP direct binding to DNA by itself is not being affected. 2) It is 
possible that the NOT proteins bind directly to TBP and prevent the interaction of 
TBP with other stabilizing factors like TFliA and SPT3. This possibility is also 
unlikely since no direct interaction was detected between TBP and any of the NOT 
proteins tested (K. Reed and C L. Denis, unpub. observe.). 3) The NOT proteins 
might sequester certain factors such as TFIIA, SPT3, or TAFs, that function to 
stabilize TBP -DNA interactions. 4) The NOT proteins may also destabilize the TBP - 
DNA interaction by multiple mechanisms. This latter possibility is consistent with the
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fact that mutations in different not genes confer overlapping but not identical 
phenotypes ( Liu et al 1998; Collart et al 1996; Oberholzer et al 1998 ). Furthermore, 
the fact that the spt3 deletion can suppress ccr4. cafl and not 1-2 defects but cannot 
suppress notl-1 and not4-l defects ( Collart 1996) suggests that these two different 
classes of mutations affect different promoters or affect the same promoters but by 
different mechanisms.
Dosage dependent interactions between NOTs, TBP, and TAFns
Overexpression of TAFn19 in a not5 or not3-2 background gave a synthetic 
lethal or sick phenotype. Overproducing other TAFs did not elicit this phenotype nor 
did TAFn19 display this phenotype in ccr4 or cafl deleted strains. TAFn19 depletion 
from the cell has also been shown to result in specific decreased ‘TATA-less’ 
transcription from the HIS3 locus ( Moqtaderi et al 1996), suggesting that it may be 
involved in processes affected by the NOT proteins. In addition, increasing the 
dosage of NOT1 (on a low copy vector), but not any of the other CCR4-NOT 
components, specifically inhibited the Spt- phenotype of the sptl 5-122 allele. On the 
other hand, increasing the expression of NOT 1 using a high copy vector caused an 
Spt- phenotype. Overexpression of any other component of the CCR4-NOT complex 
did not suppress the his4-912 delta insertion. Similar to what was observed for sptl5- 
122, ccr4, not4. mutations, the Spt- phenotype caused by overexpression of NOT 1 
was dependent on the presence of the CATAA sequence within the delta element 
(Figure 2). One possibility that is consistent with the previously described mechanism 
is th a t, the overexpressed NOT1 binds some component(s) of the CCR4-NOT
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complex (such as not4 or cafl) and sequesters it resulting in a condition that mimics 
the deletion of that component(s). These genetic interactions suggest that there exists 
a dosage dependent interaction between the CCR4-NOT proteins, TBP, and pol II 
TAFs, an interaction that is consistent with several of the above described models for 
CCR4-NOT function.
Components o f the CCR4-NOT complex physically interact with TBP and 
associated factors
This model predicts that the CCR4-NOT complex or components therein 
should physically interact with TBP and/or its associated factors. I have found that 
NOT2 and NOT5 do indeed co-immunoprecipitate with TBP. This co- 
immunoprecipitation occurred regardless of whether TBP was first 
immunoprecipitated or NOT5 was first immunoprecipitated. Relatedly, NOT1 was 
shown to be retained from crude extracts by GST-TBP (Lee et al 1998). I failed, 
however to detect NOT4, CCR4, and CAF1 in our TBP immunoprecipitates. These 
differences may derive from the physical associations observed within the CCR4- 
NOT complex (Figure 14 and Bai et al 1999 ). We found that NOT2 and NOT5 can 
associate independently of CCR4 and CAF1 and that NOT2 and NOT5 associate with 
a different part of NOT1 than do CCR4 and CAF1 ( Bai et al 1999). These 
observations suggest that NOT2 and NOT5 could function independent of CCR4, 
CAF1, and perhaps NOT4. The synthetic lethality of not4 and not5 double deletions 
(Oberholzer et al 1998), further suggests that NOT4 and NOT5 proteins have 
different roles and therefore separate functional and physical interactions in the
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CCR4-NOT complex. The immunoprecipitation data is also consistent with the fact 
that ccr4 and cafl mutations do not confer 3-AT resistance in any of the strains 
containing the modified HTS3 promoters in contrast to the 3-AT phenotype conferred 
by not5. Further, it was found that TAFn130 and TAFn90 specifically co- 
immunoprecipitate with NOT5 but not with CCR4 (Komamitsky et al 1998) and that 
GST-NOT2 and GST-NOT5 specifically interact with and retain TBP, SPT3 and 
several TAFs which are components of I'FUD and SAGA. Interaction of NOT2 and 
NOT5 with SPT3 and the TAFns which are SAGA components is consistent with a 
recent report demonstrating a physical association of the SAGA components ADA2 
and GCN5 with NOT2 (Benson et al 1998). On the other hand, NOT5 can co- 
immunoprecipitate TBP and TAFn130, and GST-NOT5 can retain TAF^O, which are 
present only in TFUD and not in the SAGA complex (Grant et al 1996). These 
results suggest that the NOT proteins may be capable of making multiple contacts 
with TFUD and SAGA components.
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Figure 14: Proposed structure of the CCR4-NOT complex.
Taken from Bai et al 1999.
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NOT2 and NOT5 interact with distinct TAF-containing complexes
The interactions between the CCR4-NOT complex and I  hJLLD as well as 
SAGA were further investigated using purified T M L D  and SAGA complexes. The 
results from these binding experiments indicate that NOT2 and NOT5 associate with 
components of distinct complexes. NOT5 was found to associate with and retain 
several proteins from purified TFLLD, including TAFn130, TAFn61 TAFn60, TAFn19 
and TBP. Interestingly, while NOT5 retains TAFn61 and TAFn60 from purified 
TFUD, it does not bind the same proteins when they are part of the purified SAGA 
complex. Similarly NOT2 retains TAFn90 and TAFn6 1 from purified SAGA but does 
not associate with the same proteins when they are part of the purified TFELD 
complex. These results demonstrate the specificity of the interactions between NOT5 
and components of TFUD and between NOT2 and components of SAGA. It is also 
clear that the interactions of NOT5 and NOT2 with TFEDD and/or SAGA in vivo may 
be more complex than what we observe using purified TFEDD or SAGA complexes. 
For instance, we observe that TAF^O can be retained from crude extracts by GST- 
NOT5 but TAFn40 as a part of purified TFUD did not bind GST-NOT5. Similarly 
GCN5 from crude extracts was shown to bind NOT2 (Benson et al 1998.) but I found 
no interaction between GCN5 and NOT2 using purified SAGA. Apparently, in vivo, 
multiple contacts between TFUD and/or SAGA may be made to the CCR4-NOT 
complex, resulting in more robust interactions than what we observe in our in vitro 
binding experiments.
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It should also be mentioned that the interactions of NOT2 and NOT5 with 
TFUD and SAGA components is consonant with a distinct location of NOT2 and 
NOT5 in the CCR4-NOT complex ( Bai et al 1999). These two proteins interact with 
the C-terminal region of NOT1 whereas CCR4 and CAF1 bind to a central section of 
NOT1. In addition the NOT2 and NOT5 proteins appear to be very closely associated 
physically ( Bai et al 1999). The general dissimilarity in function between CCR4 and 
CAF1 and the that of NOT2 and NOT5 can now be better understood as not only as a 
result of physical separation of these subsets of proteins but also from the 
distinctiveness in physical interactions. CCR4 and CAF1 do not interact with TAFs, 
TBP or GCN5 ( Komamitsky et al 1998; Chiang et al 1996) whereas NOT2 and 
NOT5 do. Since ccr4 or cafl disruptions are lethal when combined with that of not2 
or not5 (Bai et al 1999) it implies that CCR4 and CAF1 are acting by a separate 
biochemical mechanism to affect gene expression.
Based on these results two possible mechanisms can be envisaged by which 
the CCR4-NOT complex functions. 1) The interaction of the CCR4-NOT complex 
with TFUD or SAGA could disrupt these complexes thereby preventing their 
function. This model is based on the observation that NOT5 and NOT2 retain only a 
subset of proteins from TFUD and SAGA respectively.
The model that NOT5 represses TBP activity by disrupting the TFUD 
complex can be tested by two approaches - i) Purified TFUD can be mobilized on an 
anti-TBP antibody column and the affect of purified NOT5 addition on the integrity 
of the immobilized TFUD can be monitored by probing the column washes for
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presence of TFIED components. Purified NOT2 which does not interact with TFUD 
can be used as a negative control. Since it is possible that the anti-TBP antibody could 
mask an epitope required for TFIID-NOT5 interactions, the purified TFDD complex 
can also be immobilized on a GST-ADR1-TADIV column (Komamitsky et al 1998). 
TADIV (TransActivation Domain IV) of ADR1 has been shown to bind and retain 
purified TFEID in stoichiometric amounts ( V. B and J.H.F. unpubl. obs.). 
n) A genetic approach to test the TFUD disruption model would utilize the K151L, 
K156Y allele of TBP. This allele of TBP is unable to maintain the integrity of TFUD 
at elevated temperatures (Ranallo et al 1999), presumably due to weaker TBP-TAF 
interactions. It has been shown that, at elevated temperatures several of the TAFs 
including TAFn130, TAFn90, TAFn61 and TAFn25 fail to associate with TBP. 
Therefore, if NOT5 did function by disrupting TFIED, then it is likely that 
overexpression of NOT5 would exacerbate the effects of the K1511, K156Y allele of 
TBP and perhaps result in synthetic lethality.
In case of NOT2, under conditions wherein GST-TBP was found to retain all 
components of SAGA tested, GST-NOT2 retained only two out of four components 
tested. The two components retained by NOT2 include TAFn90 and TAFn61. It has 
been reported that TAFn61 is required for the the acetylation of nucleosomal histones 
by the SAGA complex (Grant et al 1998). Therefore, NOT2 could repress 
transcription by binding and removing TAFn61 from the SAGA complex thereby 
inhibiting the nucleosomal histone acetylation (ELAT) activity of the complex. This 
model can be tested by experiments similar to those described in (i), using
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immobilized SAGA complex and purified NOT2. In addition, the effect of NOT2- 
TAF61 interaction on the nucleosome acetylation by SAGA can tested by carrying 
out nucleosomal HAT assays for SAGA in presence of purified NOT2.
2) The alternative model is that, the CCR4-NOT complex could sequester TFUD or 
SAGA thereby affecting TBP function at certain promoters. For example TAFn130 
and TAFn19 have been shown to be required for transcription from non-consensus 
TATA elements such as the Tc element of the HIS 3 gene and the TRP3 promoter 
(Moqtaderi et al 1996, 1998). Therefore the binding of NOT5 to TAFn130 and 
TAFn19 may modulate their activity or prevent their access to these promoters. This 
model can be tested by determining if purified NOT5 or CCR4-NOT complex affects 
the ability of purified TFEDD to bind non-consensus TATA DNA sequences. In these 
experiments, the DNA containing a non-consenus TATA element will be 
immobilized on magnetic beads as described in Ranish et al 1999. Purified TFIED will 
be incubated with the immobilized DNA in appropriate binding buffer. Following 
several washes, the binding of T F U D  to the DNA will be determined by Western 
blotting for various components of TFUD, subsequent to boiling the DNA- beads in 
SDS loading buffer and running it on an SDS-PAGE gel. Immobilized DNA lacking 
any TATA-like sequences will be used as a negative control. The binding of TFUD to 
non-consensus TATA elements will subsequently be carried out in the presence of 
purified NOT5 or purified CCR4-NOT complex, to determine if the presence of these 
proteins block or inhibit the ability of TPlLD to bind non-consensus TATA elements.
79
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Interaction between TFIIA and the CCR4-NOT complex
While investigating the possibility that the CCR4-NOT complex modulates 
the activities of factors that bind TBP, TFIIA was found to be a possible target for 
repression by the CCR4-NOT complex. Initial experiments indicated that increasing 
the concentration o f TFIIA had similar affects on transcription from non-consensus 
TATA elements as deleting not4 or not5.Subsequent analysis indicated that this effect 
of TFIIA was not due to titration or squelching by individual subunits of TFIIA. It 
was found that the effect of overexpression of TFIIA on expression from non­
consensus promoters required the function of TFIIA and interaction between TFIIA 
and TBP. TFIIA function as well as TBP-TFUA interactions have been shown to be 
required for optimal transcription from the native HIS 3 promoter and our results 
indicated that TFILA-TBP interaction was also required to maintain the low -level 
transcription from the non-consensus TATA containing his3 promoter derivatives. 
This suggests that TFIIA activity as well as TBP-TFiiA interactions are required at 
these promoters, primarily for other functions distinct from overcoming repression by 
the CCR4-NOT complex. Therefore, the repressive effect of the CCR4-NOT complex 
on TBP function is not mediated exclusively through TFIIA. Biochemical evidence 
consistent with this possibility indicates that interaction between the CCR4-NOT 
complex and TBP is not mediated by TFIIA and does not require TBP-TFIIA 
interaction. However, it is possible that the NOT5- IFILA interactions that were 
observed, were mediated by one or more of the TAFs that have been shown to 
associate with NOT5. Interaction between TAFs and TFIIA have been previously
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reported (Sun et al 1994; Yokimori et al 1993). Considering the genetic evidence that 
TFHA-TBP interaction is required at the native HIS3 promoter and at the his3 
promoter derivatives used in this study, and the biochemical evidence that NOT5 
interacts with TBP independent of TBP-TFIIA interactions, it seems unlikely that 
TFIIA is a direct target of the CCR4-NOT complex.
A genetic approach to test if TFIIA is a direct target of the CCR4-NOT 
complex would be utilize known mutations in TFIIA that are defective for a specific 
function such as TBP binding, DNA binding or TOA1-TOA2 interactions (Kang et al 
1995; Ozer et al 1998). If one function of TFIIA is to overcome repression by the 
CCR4-NOT complex, then some of the effects of these TFIIA mutants should be 
alleviated by mutations in the NOT genes.
Another method of testing if TFIIA is a direct target is to investigate whether 
purified /recombinant TFIIA can associate with GST-NOT5 or GST fusions of other 
components of the CCR4-NOT complex. If TFIIA does associate with one or more 
components of the CCR4-NOT complex, then the binding domain on either subunit 
of TFIIA can be mapped by deletion analysis. Subsequently this CCR4-NOT binding 
domain on TOA1 and/or TOA2 can be mutagenized to isolate mutants that fail to 
associate with the CCR4-NOT complex. Since these TFIIA mutants will be unble to 
interact with the CCR4-NOT complex, they should exhibit phenotypes similar to that 
displayed by not deletions. Therefore, if TFIIA is a direct target of the CCR4-NOT 
complex, then TFUA mutants that fail to interact with the CCR4-NOT complex
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should allow increased expression from the Tc element as well as from the other HTS3 
promoter derivatives used in this study.
If no association between purified/recombinanat TFIIA and GST fusions of 
CCR4-NOT components is detected, then it is likely that the NOT5-TFHA 
interactions are mediated by the TAFs that have shown to associate with NOT5. This 
hypothesis can be tested using the K151L, K156Y allele of TBP (Ranallo et al 1999), 
that has been described in the previous section. Since this allele of TBP results in the 
disruption of TFUD at elevated temperature, it is possible that a subset of TAFs from 
TFUD that normally associate with NOT5, would fail to do so at elevated 
temperature. If under similar conditions TOA2 fails to associate with NOT5, it can be 
inferred that the TFTLA-NOT5 interaction is mediated by one or more components of 
TFUD.
The data from all the genetic and biochemical analysis described above 
indicate that components of TFUD and SAGA are targets for repression by the 
CCR4-NOT complex. Hence the effects of not4 or not5 deletion on transcription from 
the non-consensus TATA elements are presumably due to increased access or 
increased activity of components of TFUD and/or SAGA. It is conceivable that the 
effect of overexpression of TFIIA on the same promoters is due to increased access of 
TFUA to these promoters where it could overcome the repressive effects of the NC2 
complex or MOT1.
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The NOT proteins are part of th e  CCR4 
transcriptional complex and affect gene expression 
both positively and negatively
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The CCR4 transcriptional regulatory complex con­
sisting of CCR4, CATT, DBF2 and other unidentified 
factors is one of several groups of proteins that affect 
gene expression. Using mass spectrometry, we have 
identified the 195,185 and 115 IcDa species which are 
part of the CCR4 complex. The 195 and 185 kDa 
proteins were found to be NOT1 and the 116 kDa 
species was identical to NOT3. NOT1, 2, 3 and 4 
proteins are part of a  regulatory complex that nega­
tively affects transcription. All four NOT proteins were 
found to co-immunoprecipitate with CCR4 and CAF1, 
and NOT1 co-purified with CCR4 and CAF1 through 
three chromatographic steps in a complex estimated 
to be L2X104 Da in size. Mutations in the NOT  genes 
affected many of the same genes and processes tha t are 
affected by defects in the CCR4 complex components, 
including reduction in ADH2 derepression, defective 
cell wall integrity and increased sensitivity to mono- 
and divalent ions. Similarly, cer4, cafl and dbf2 alleles 
negatively regulated FVSl-lacZ  expression, as do 
defects in the NOT  genes. These results indicate that 
the NOT proteins are physically and functionally part 
of the CCR4 complex which forms a unique and novel 
complex that affects transcription both positively and 
negatively.
Keywords: activarion/CCR4/NOT proteins/repression/ 
transcription
Introduction
There are a number of general reguiatory complexes r h a r  
are involved in transcriptional processes. For example, in 
addition to the yeast holoenzyme that contains the SRB 
proteins (Wilson e ta l, 1996), the SPT3-ADA2-GCN5 
complex (Grant er aL, 1997), the NOT complex (Collart 
and Struhl. 1994), the PAF1 holoenzyme (Wade er aL,
1996) and the CCR4 complex have all been identified as 
playing roles in affecting gene transcription. Each of these 
groups of proteins appears to be unique. The interaction 
and functional relationship of these groups of transcrip­
tional regulatory factors, however, remain to be clearly 
established. In this study, we demonstrate that the NOT 
protein complex is part of the CCR4 transcriptional
1096
complex and that these two groups of proteins share 
overlapping functions.
CCR4 affects the expression of many genes and pro­
cesses in yeast. It is required for the expression of ADH2 
and other non-fcrmcntarivc genes (Denis, 1984; Denis and 
Malvar, 1990) and for unidentified genes involved in cell 
wall integrity (Liu er aL, 1997). card mutations result in 
a partial cell cycle block during telophase and increase 
the sensitivity of yeast cells to Li~ and Mg2* (Liu er aL,
1997). ccrf is also a suppressor of sptIO mutations (Denis, 
1984), defects which result in enhanced transcription at 
ADH2 (Denis and Malvar; 1990) and other loci (Natsoulis 
er aL, 1991). In addition to acting as an activator. CCR4 
has been implicated in negatively affecting gene expression 
as well (McKenzie etaL. 1993; Schild, 1995). CCR4 is a 
component of a mnlti-subunit complex (Draper etaL, 
1994). Two of the CCR4 complex components, CAF1 
(POP2) (Sakai e ta l, 1992; Draper etaL, 1995), and 
DBF2, a cell cycle-regulated protein kinase (Toyn e ta l, 
1991), function to control many of the same processes as 
CCR4 (Liu etaL, 1997). While none of these genes by 
themselves are essential, the phenotypes conferred by the 
ccr4, cafl and dbfl mutations indicate that the CCR4 
complex is required for optimal and proper expression of 
many genes. The evolutionary conservation of CAF1 
across eucaryotes (Draper etaL, 1995) further suggests 
that this complex plays an important role in eucaryotic 
gene controL Although the mechanism of how CCR4 
functions remains unclear, the site of CCR4 action at the 
ADH2 locus has been shown to occur at a post-chromatin 
remodeling step (Verdone etaL, 1997).
In addition to CAF1 and DBF2, die CCR4 complex 
contains several unidentified proteins, 195, 185, 140 and 
116 kDa in size (Draper e ta l, 1994). Our initial attempt 
a t cloning the corresponding genes for these proteins by 
two-hybrid analysis was unsuccessful (Draper et aL, 1995; 
Liu etaL, 1997). Mass spectrometry has recently become 
the method of choice for rapid and unambiguous identi­
fication of gel-separated proteins. Large-scale analysis of 
yeast proteins is now possible (Shevchenko et aL, 1996), 
and entire yeast protein complexes can be studied (Latnond 
and Mann, 1997; Neubauer etaL, 1997). Here, we have 
used these methods to identify the 195, 185 and 116 kDa 
species of the CCR4 complex. The 185 and 195 kDa 
species were found to be NOT1 and the 116 kDa species 
was found to be NOT3.
The NOT genes have been identified as encoding a 
group of factors involved in repressing the transcription 
of HIS3 ffom a non-canonical TAXA (Collart and Struhl, 
1994). This group of proteins contains NOT1/CDC39. 
NOT2/CDC36. NOT3 and NOT4/MOT2/SIG1. and 
genetic evidence indicates that they function as a complex 
in vivo (Collart and Struhl, 1993, 1994). In addition to 
affecting H1S3 expression, the not mutations augment the
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expression of many genes or reporter genes, confirming 
their role as a repression complex (Cade and Errede, 1994: 
Collart and Struhl, 1994; Irie etaL, 1994; Collart, 1996). 
Of the four NOT genes, only NOT1 was found to be 
essential. We have subsequently shown that NOT2 and 
NOT4 also associate with the CCR4 complex. Genetic 
analyses reveal that NOT defects result in phenotypes 
similar to those observed with the deletion of CCR4 and 
its associated components. These results indicate that the 
CCR4 complex includes die NOT proteins and that this 
complex can affect gene transcription both positively and 
negatively.
Results
The 185/195 and 115 kDa proteins in the CCR4 
complex are NOT1 and NOT3
To identify the proteins which associate with CCR4, the 
CCR4 complex was isolated by immunoptecipitation. 
Yeast extracts, containing either a LexA-CAFI fusion 
protein or just LexA alone, were incubated with an 
antibody directed against the LexA protein, and the 
resulting immunoprecipitates were subjected to SDS- 
PAGE (Figure 1). After staining the proteins, the 116, 185 
and 195 kDa species that specifically co-irmnunoprecipi- 
tared with CCR4 (Draper etaL. 1994) were isolated and 
were analyzed by mass spectrometry using the strategy 
previously described (Shevchenko ec a t ,  1996). A small 
aliquoc of the peptide mixture resulting from in-gel diges­
tion o f the bands was analyzed by matrix-assisted laser 
desorption/ionization (MALDI). High resolution peptide 
mass maps were obtained of all three bands which were 
analyzed. Database searches with the set of measured 
masses resulted in the following identifications: band 
116 kDa was N0T3, band 185 kDa was NOT1 and band 
195 kDa was also NOT1. The identification of NOT3 was 
performed by MALDI peptide mapping only. The database
search revealed that 26 measured peptide masses fit die 
sequence of NOT3 within a mass accuracy of 50 p.p.m. 
This corresponds to 30% of the sequence. The other two 
bands were subjected to both MALDI peptide mapping 
and mass spectra metric sequencing using nanoelectospray 
(Wilm etoL. 1996). The peptide maps covered 29% of 
the protein in the band migrating at 185 kDa and 32% of 
the protein in the band migrating at 195 kDa. The 
identification of the lower band is shown in Figure 2. 
Sequencing of 10 of the peptides derived from the 185 kDa 
band and eight of the peptides derived from the 195 kDa 
band confirmed the identification (data not shown). No 
peptides of the N-terminal region of the NCJT1 protein 
were found in the analysis of the lower band. Thus, the 
data are consistent with the N-tenninal truncation of the 
NOT1 protein suggested bv previous studies (Collart, 
1996).
N0T2 and NOT4 are also in the CCR4 complex
The NOT1 and NOT3 proteins have been shown to be 
pan of a complex that also includes the NOT2 and 
N0T4 proteins (Collart and StruhL 1994). To examine the 
possibility that the NOT2 and NOT4 proteins were also 
part of the CCR4 complex, we carried out a series of 
immunopredpitation experiments. We first examined the 
association of NOT1 with CCR4. A LexA-NOTl fusion 
was expressed in a wild-type strain. LexA-NOTl was 
immunoprecipitated with the LexA antibody while the 
CCR4 complex was immunoprecipitated with the CCR4 
antibody. The resulting immunoprecipitates were subjected 
to Western blot analysis (Figure 3A). CCR4 co-immuno- 
precipitated with LexA-NOTl (Figure 3A, lane 3) while 
LexA-NOTl along with the NOT! proteins (185/195 kDa) 
were co-immunoprecipitated with CCR4 (Figure 3 A. lane 
5). These results m nfirm the protein sequencing data.
To investigate the association of NOT2 with the CCR4 
complex, a LexA—NOT2 fusion was expressed in a wild- 
type strain, a ccr4A strain and a cqj7A strain. An antibody 
raised against the LexA protein was used to itnmunopre- 
cipicate the LexA—NOT2 fusion while antibodies raised 
against either CCR4 or CAF1 were used to bring down 
CCR4 and CAF1. respectively. The resulting immunopre- 
dpitates were subjected to SDS-PAGE, followed by 
Western blot analysis (Figure 3 A and B). Immunoprecipit- 
ating LexA—NOT2 with the LexA antibody resulted in 
co-immunopredpitation of NOT1 from the wild-type, 
ccr4A and caflA  extracts (Figure 3A, lane 4, and B, lanes 
I and2, respectively). CCR4 co-immunopredpitated along 
with LexA-NOT2 and NOT1 from the wild-type strain 
(Figure 3A  lane 4), but not from the caflA  strain 
(Figure 3B, lane 1). When the CCR4 antibody was used 
to repeat the immunopredpitation experiments, the NOT1 
and LexA-NOT2 proteins were found to co-immuno- 
prcdpitare with CCR4 from the wild-type strain 
(Figure 3A. lane 6), but not from the strains lacking either 
CAFl (Figure 3B, lane 3) or CCR4 (Figure 3B, lane 4). 
Longer exposures of the results presented in Figure 3B, 
lane 3, indicated that a small amount of NOT1 and LexA- 
NOTl was found to co-immunopredpitate with CCR4 
from the caflA  strain (data not shown). These results 
indicate that NOT2 physically interacts with both CCR4 
and NOT1, and that the assodation of CCR4 with the 
NOT proteins is largely dependent on the presence of
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CAF1. The immtmoprecipitarion experiments were also 
repeated by using the CAF1 antibody. NOTl, LexA- 
NOTl and CCR4 were found to co-immunopredpitaie 
with CAF1 from the wild-type strain (data not shown), 
and NOTl and LexA-NOT2 were co-immanopredpitated 
with CAFl from the ccrdA strain (Figure 3B. lane 6). 
However, NOTl and LexA—NOTl failed to co-immuno- 
predpitate with the CAFl antibody from the caflA strain 
(Figure 4B, lane 7), confirming that LexA-NOT2 does not 
immunopredpitate fortuitously with the CAF1 antibody. 
These results' also suggest that the interaction between 
CAF1 and the NOT proteins is CCR4 independent 
To address the question as to whether NOT4 was in 
the CCR4 complex, a c-Myc-tagged NOT4 fusion was 
expressed along with LexA-CAFI in a wild-type strain. 
Extracts treated with the LexA antibody resulted in co- 
immunopredpitarion of c-Myc-N0T4 with LexA-CAFI. 
CCR4 and NOTl (Figure 4A, lane 3). while the LexA pre- 
immune serum failed to immunopredpitaie these proteins 
(Figure 4A  lane 2). The c-Myc-N0T4 protein dso co- 
immunopredpitated with CCR4 and NOTl when the 
extracts were immunopredpitated with dther CAF1 anti­
body (Figure 4 A  lane 4) or CCR4 antibody (Figure 4A  
lane 5). Immunopredpitation with the c-Myc antibody, in 
turn, was able to bring down LexA-CAFI, CCR.4 and 
NOTl along with c-Myc-NOT4 (lane 6). We also immuno- 
predpitated the CCR4 complex from an extract prepared 
from a strain expressing both LexA-NOT2 and c-Myc- 
N0T4 fusion proteins. The resulting immunoprecipitates 
were analyzed by Western blot (Figure 4B). It is clear that
NOTl, NOT2 and N0T4 co-immunoprecipitated with 
CCR4 and CAF1. Because NOT3 is also in the CCR4 
complex as determined by mass spectrometry, we condude 
that the complete NOT repressive tegulatory complex is 
part of the CCR4 complex.
Two-hybrid analysis was used further to examine the 
interaction of die NOT proteins and the CCR4 complex 
components. As shown in Table L both B42—NOTl and 
B42-NOT2 interacted with LexA-CAFI, and LexA- 
NOTl was found to interact with B42-CAF1- LexA- 
CCR4 interacted with B42-NOT1, and B42-DBF2 inter­
acted well with LexA-NOT2. The moltiplirity of these 
interactions confirms the above-described protein analyses.
The CCR4 com plex is a unique transcriptional 
regulatory complex
Our previous studies on CCR4 indicated that the CCR4 
complex is a transcriptional regulatory complex distinct 
from that of several other complexes such as the SNF/ 
SWI complex, the yeast holoenzyme and the putative 
SPT4, 5. 6 complex (Denis etaL, 1994). The size of the 
CCR4 complex was estimated following Superose 6 gel 
filtration chromatography. As shown in Figure 5A. CCR4 
migrated in two separate peats of I.9X106 and I.OxlO6 
Da. In other experiments, a small portion of CCR4 
migrated at 2.0x10s Da, which is close to the size of 
CCR4 and may represent monomeric CCR4 (Figure 5C, 
top panel). The two larger complexes were also unaffected 
by prior DNase treatment, suggesting that they do not 
result from non-specific binding to DNA (Figure 5A. dam
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not shown). The 1.9X 10s Da CCR4 complex is separate 
from that of the SRB complex which, as analyzed on a 
longer Superose 6 column, migrated at 1.7X10® Da 
(Figure 5B). Moreover, in a caflA strain, most of the 
CCR4 protein was found at the l.Ox 105 Da size, indicating 
that the CAFI protein is requited for CCR4 association 
in the 1.9X10® and 1.0x10“ Da complexes (Figure 5C, 
top two panels). A cafl A  had no effect, however, on the 
ability of the non-CCR4 complex component, SPT10. to 
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L e x A  a n d  c - M y c  a n t i b o d i e s .  ( B )  Y e a s t  w h o l e  c e l l  e x t r a c t s  c o n t a i n i n g  
L e x A —N 0 T 2  a n d  c - M y c - N O T 4  w e r e  t r e a t e d  w i t h  c - M y c  a n t i b o d y  
( l a n e  I ) .  L e x A  a n d b o d y  ( l a c e  2 )  o r  C C R 4  a n t i b o d y  ( l a c e  3 ) .  T b e  
r e s u l t i n g  i m m u n o p r e c i p i t a t e s  w e r e  s u b j e c t e d  t o  h n n u m o b l o t  a n a l y s i s  
a n d  p r o b e d  w i t h  N O T l .  C C R 4 .  c - M y c .  N O T 2  a n d  L e x A  a n t i b o d i e s .
T a b l e  L  T w o - h y b r i d  i n t e r a c t i o n  a s s a y
f t - G a l  a c t i v i t y  ( U / m g )
B 4 2 - N 0 T 1  B 4 2 - N O T 2  3 4 2 - C A F 1  3 4 2 - D B F 2  3 4 2
L e x A - N O T l  - 1 3 0 _ 3 . 6
L e x A - N O T 2  - 9 0 0 2 7 0 6 6 0 1 1 0
L e x A - C C R A  3 3 0 uoo 7 4 6 . 4
L e x A - C A F I  U Q 0 3 8 0 _ 9 3 0 8 6
L e x A  < 2 < 2 <2 < 2 < 2
L e x A - C C R 4 .  - N O T l  a n d  - N O T 2  c o n t a i n  f u l l - l e n g t h  C C R 4 ,  N O T l  
a n d  N O T 2 .  L e x A - C A F I  c o n t a i n s  r e s i d u e  1 2 7 - 4 4 4  o f  C A F L .  A l l  
L e x A  f u s i o n s  c o n t a i n  r e s i d u e s  1 - 2 0 2  o f  L e x A .  3 4 2 - N O T 1 .  - N O T 2  
a n d  - D B F 2  c o n t a i n  f u l l - l e n g t h  N O T L  N 0 T 2  a n d  D B F 2 .  B 4 2 - C A F I  
c o n t a i n s  r e s i d u e s  1 4 8 - 4 4 4  o f  C A F I .  -  i n d i c a t e s  t h e  B - g a l a c r a s i d a s e  
a c t i v i t y  i s  n o  g r e a t e r  t h a o  t h e  b a c k g r o u n d  i n t e r a c t i o n  w i t h  B 4 2  a l o n e .
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F i g .  S .  A n a l y s i s  o f  t h e  C C R 4  c o m p l e x e s  u s i n g  g e l  f i l t r a t i o n  
c b r o n a i o g m p h y .  ( A )  Y e a n  w h o l e  c e l l  e x t r a c t s  p r e p a r e d  f r o m  a  w i l d -  
t y p e  s t r a i n  a n d  t r e a t e d  w i t h  D N a s e  w e r e  c h r o m a t o g r a p h e d  o n  a  
S u p e r o s e  6  H R 1 Q / 3 0  c o l u m n .  T h e  r e s u l t i n g  I  m l  t r a c t i o n s  ( 3 0  ( l i  o f  
e a c h  t r a c t i o n )  w e r e  s u b j e c t e d  t o  i m m u n o b l o t  a n a l y s i s  a n d  p r o b e d  w i t h  
C C R 4  a n t i b o d y .  T h e  t w o  a r r o w s  i n d i m f e  t h e  s i z e  o f  t b e  t w o  p e a k s  
c o n t a i n i n g  C C R c .  ( B )  Y e a s t  w h o l e  c e i l  e x t r a c t s  w e r e  c h r o m a t o g r a p h e d  
o n  a n  e x t e n d e d  S u p e r o s e  6  H R  1 6 / 5 0  c o l u m n .  T h e  r e s u l t i n g  1 m l  
f r a c t i o n s  ( f i r s t  1 2  f r a c t i o n s )  w e r e  s u b j e c t e d  t o  i m m u n o b l o t  a n a l y s i s  
a n d  p r o b e d  w i t h  C C R 4  a n d  S R B S  a n r i b o d i r s .  T h e  a n e w  i n d i c a t e s  t h e  
p e a k  c o n t a i n i n g  S R B S .  ( C )  Y e a s t  w h o l e  c e l l  e x t r a c t s  p r e p a r e d  b o m  a  
w i l d - t y p e  o r  a  ccfl - d e l e t e d  s t r a i n  w e r e  c h r o m a t o g r a p h e d  o t r  t h e  
S u p e r o s e  f i  H R I Q / 3 0  c o l u m n .  T h e  r e s u l t i n g  1 m l  f r a c t i o n s  (every o t h e r  
t r a c t i o n  i s  d i s p l a y e d )  w e r e  s u b j e c t e d  t o  i m m u n o b l o t  a n a l y s i s  a n d  
p r o b e d  f o r  C C R 4  ( t o p  t w o  p a n e l s )  a n d  S P T 1 0  ( b o t t o m  t w o  p a n e l s ) .  
'CAFI' a n d  'ca fl' i n d i c a t e  t b e  w i l d - t y p e  a n d  c o / 7 - d e l e t e d  s t r a i n s ,  
r e s p e c t i v e l y .  T h e  1 2 0  k D a  b a n d  t h a t  r u n s  a b o v e  C C R 4  i n  t h e  C C R 4 -  
p r o b e d  p a n e l  i s p c e s e a s  a  c o o - s p e c i f i c  p r o t e i n  a n d  s e r v e s  a s  a n  i n t e r n a l  
c o n n o l  f o r  t h e  e x p e r t  t n e n r , B a s e d  o n  t h i s  c o n t r o l ,  t h e  a m o u n t  o f  
p r o c e i n  l o a d e d  f o r  d i e  'CAFI' e x p e r i m e n t  w a s  a b o u t  t w i c e  t h a t  o f  t h e  
'c c fl' e x p e r i m e n t ,  r e s u l t i n g  i n  t h e  d e e r r n s r r i  l e v e l  o f  C C R 4  p r o t e i n  
v i s i b l e  i n  t h e  ‘c u f f ' c x p e r i m e n t  f o r  t b e  S P T 1 0  W e s t e r n  ( b o t t o m  p a n e l ) .
nor on the SRB5 protein to migrate at 1.7XI06 Da (data 
not shown).
To analyze the CCR4 complex farther, we isolated the 
CCR4 complex from a strain in which the CAFI gene 
was deleted and a CAFI gene tagged at its C-terminus 
with 6xHis was integrated into the genome at the TRPI 
locus. This CAFI-6His gene was able to complement the 
defect of ccfl A (Liu er aL, 1997). The extracts prepared 
from this strain were first put onto a Ni3+-NTA column, 
and the bound proteins was eluted with 220 mM imidazole. 
The NOTl protein and CAFl-SHis were found to co- 
itnmunoprecipitaie with CCR4 when the Ni3* eluate was 
treated with CCR4 antibody (data not shown). The Ni1'  
eluate subsequently was loaded onto a Mono Q column, 




F i g .  S .  C o - p u r i f i c s r i o n  o f  t h e  N O T l  p r o t e i n  a n d  t h e  C C R 4  c o m p l e x .  
Y e a s t  w h o l e  c e l l  e x t r a c t s  p t s p a r e d  f r o m  a  c a f l - d o l e t r d  s t r a i n  
c o n t a i n i n g  CAFI~6His i n t e g r a t e d  a r  t h e  TRPI l o c u s  w e r e  
c h r o m a t o g r a p h e d  o n  a  N 1 2 ~ - N T A .  M o u o  Q  a n d  S u p e r o s e  €  H R 1 0 / 3 0  
c o l u m n  a s  d e s c r i b e d  i n  M a t e r i a l s  a n c  m e t h o d s  F r a c t i o u s  o f  O S  m l  
f r o m  t h e  S u p e r o s e  €  c h r o m a t o g r a p h y  w e r e  s u b j e c t e d  t o  i m m u n o b l o c  
a n a l y s i s  a n d  p r o b e d  f o r  N O T l .  C C R 4  a n d  C A F I .  T b e  M o n o  Q  l a n e  
r e f e r s  t o  t h e  p e a k  f r a c t i o n  f o l l o w i n g  M o u o  Q  c h r o m a t o g r a p h y  t h a t  w a s  
a p p l i e d  t o  t h e  S u p e r o s e  6  c o l u m n .  T b e  N r ^ - N T A  e l u a t e  w a s  c o t  
p r o b e d  f o r  N O T l .  T b e  a r r o w  i n d i c a t e s  t h e  size  o f  t h e  p e a k  e l u t e d  
f r o m  t h e  S u p e r o s e  6  c o l u m n  t h a t  c o n t a i n s  N O T l .  C C R 4  a n d  C A H -  
6 H i s .
The Mono Q fractions were analyzed by Western blot 
using both CCR4 and CAFI antibody, and CCR4 and 
CAFl-6His were found to co-elute (Liu etal.. 1997; 
Figure 6). Fractions containing both CCR4 and CAFI 
were pooled and the proteins were analyzed further by 
Superose 6 gel filtration chromatography. The fracdons 
from these different steps in purification were subjected 
to Western bloc analysis. The purified CCR4 complex 
displayed a molecular weight of 1.2X106 Da following 
the Superose 6 gel filtration chromatography (Figure 6), 
corresponding closely to the 1.0x10s Da CCR4 complex 
observed in crude extracts (Figure 5A). NOTl, CCR4 and 
CAFI were all found to co-purify through these three 
purification steps. In contrast. Western bloc analysis nsing 
antibodies against SRBS and SRB6 failed to detect either 
of these proteins in the Mono Q and Superose 6 fractions 
(data not shown). These data indicate that NOTl, CCR4 
and CAFI are components of the same complex. In 
addition, the 1.9X10“ and 1.2x10s Da CCR4 complexes 
appear distinct from the yeast holoenzyme containing the 
SRB complex.
Mutations in the NOT genes result in similar 
phenotypes to  those observed with ccr4 and cafl 
alleles
The presence of the NOT proteins in the CCR4 complex 
suggest that they should function to control similar genes 
and processes as do CCR4 and its associated components. 
However, the NOT proteins have been characterized as a 
repression complex and CCR4 is generally considered to 
be an activator. To address this issue, we analyzed the 
effect of not mutations on several processes known co be 
affected by ccr4. The results from the phenotypic analyses 
are summarized in Table IL Mutations in the NOT genes 
except for NOT3 reduced ADH2 expression under non- 
fermentative conditions, indicating that the NOT proteins 
can act as activators. A not4 allele was also capable of 
suppressing the enhanced ADH2 expression that is caused
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CC84-NOT com plex
T a b l e  U .  P h e a o c y p i c  a n a l y s i s
S t r a i n s A D H  DC sptlO 
A D H  H
C a f f e r o e  
3  m M
3 7 - C
Y D
3 7 * C Y D  
I  M  s o r b i t o l
M g 1 ’* 
7 5 0  m M
S t a u r o  
I  m g / m I
3  A T  
2 0  m M
w t 2 4 0 0 9 1 -
ccr* 4 0 0 2 3 - - + _ -
cafl 1 0 0 0 7 w - - _ - w / —
notl 1 3 0 0 7 8 - w w _ _ ■r
nat2 3 4 0 8 6 + w Jr
notS 2 5 0 0 N D . ■h - w 4 -
not* 1 2 0 0 1 3 V - w w - • f
G r o w t h  w a s  s c o r e d  o n  Y D  p l a t e s  a s  s u p p l e m e n t e d  w i h i  3  m M  c a f f e i n e .  I  m g f m i  o f  s t a u r o s p o t i n e  ( s r a a r o ) .  7 5 0  m M  M g Q .  o r  I  M  s o r b i t o l  a s  
t w t i — w t  3 A D  g r o w t h  w a s  s c o r e d  o a  m i n i t n a i  p l a t e s  l a c k i n g  h i s t i d i n e  a n d  c o n t a i n i n g  2 0  m M  3 - a m i n o t n a z o l e  ( 3 A T )  n s i a g  s i x a i n s  i s o g e n i c  t o  K Y 8 0 3  
(Wt; c o c m m i c g  t h e  Y C p 8 8 - S c 4 3 6 3  p l a s m i d  ( C o l l a r t  a n d  S t r u h l .  1 9 9 4 ) .  S t r a i n s  u s e d  f o r  m o n i t o r i n g  c a f f e i n e ,  t e m p e r a t u r e  a n d  s t a u t o s p o n n e  
s e n s i n v t t y  w e r e  K Y 8 0 3  ( w t ) .  E G Y 1 8 8 - L  ( c c r 4 ) .  E G Y  1 8 8 - c l  ( c c / J l ,  M Y 3  ( n o r / ) ,  M Y 1 6  ( n o c 2 ) .  M Y 5 0 8  ( n o d )  a n d  M Y 5 3 7  ( n o t 4 ) .  W i l d - t y p e  s t r a i n  
E G Y 1 8 8  g a v e  t h e  s a m e  r e s u l t s  a s  K Y 8 0 3 .  A D H  E  a c t i v i t i e s  ( m U / m g )  r e p r e s e n t  t h e  a v e r a g e  o f  a t  l e a s t  t h r e e  d e r e n n i n a t i o n s  a n d  w e r e  c o n d u c t e d  
f o l l o w i n g  g r o w t h  a t  3 0 * C  o n  Y E P  m e d i u m  c o n t a i n i n g  3 %  e t h a n o L  N o  e f f e c t  w a s  o b s e r v e d  i n  t h e  n o r  m t t t a n o n s  o n  A D H  I I  a c t i v i t y  u n d e r  g l u c o s e  
g r o w t h  c o n d i t i o n s  ( d a m  c o t  s h o w n ) ,  t h e  S E M  f o r  t h e  A D K  E  a c t i v i t i e s  w a s  < 2 0 % .  F o r  A D H  E  a s s a y s ,  t h e  f o l l o w i n g  s t r a i n s  w e n  u s e d :  w t .  
K Y 8 0 3 - A 3 :  r c tl.  M Y S - A I :  n o r 2 .  M Y I 6 - A 1 ;  notS.  M Y 2 5 - A I ;  note, 6 l 2 - l d - n 4 :  a n d  f o r  spzlO  A D H  E  a s s a y s  t h e  s t r a i n s  w e r e :  w t .  sptlO  s e g r e g a n t s  
f r o m  c r o s s  3 0 8 - S c  a n d  6 1 2 - l d - o 4 ;  n a il. spzlQ n c il'2  s e g m g a n t s  h o r n  c r o s s  M Y 8 A I  a n d  1366- i a ;  n o r 2 ,  spiSO not2 s e g r e g a n t s  h o r n  c r o s s  8 0 8 - 5 c  a n d  
M Y 1 6 - 0 1 :  c o r * ? .  sptJO n o il s e g r e g a n t s  f r o m  c r o s s  8 0 8 - 5 c  a n d  6 1 2 - l d - n 4 .  T h e  i s o g e n i c  p a r e n t  f o r  6 l 2 - I d - o 4  i s  6 1 2 - I d  w h o s e  A D H  U  a c t i v i t y  i s  
3 0 0 0  t n U / m g .  A D H  I I  a n d  sptlO  A D H  I I  a c t i v i t i e s  f o r  ccrl a n d  cafl s t r a i n s  a r e  t a i r e n  f r o m  D e n i s  ( 1 9 8 4 )  a n d  D r a p e r  e r  aL ( 1 9 9 5 ) .  N D . .  n o t  d o n e ;  
• + ' ,  g o o d  g r o w t h ;  ' w - .  w e a k  g r o w t h ; n o  o r  p o o r  g r o w t h .
by an sptlO defect. All o f the not alleles except for not3 
also displayed sensitivity to caffeine, a phenotype resulting 
from defects in cell-wall integrity, which is shared by the 
ccr4, cafl and dbfl alleles (Liu et a t,  1997). ccr4, cafl 
and dbf2 mutations also result in temperature- and/or cold- 
sensitive phenotypes that are supptessible by 1 M sorbitol, 
confirming their roles in control o f cell wall integrity (Liu 
et aL, 1997). In agreement with this phenotype, it has been 
shown previously that a  not4 allele confers a temperature- 
sensitive phenotype that is supptessible by I M sotbitol 
(Cade and Etiede. 1994). We subsequently found that the 
noO. ts phenotype was also relieved by 1 M sorbitol 
(Table H). Also, the caffeine-sensitive phenotype of not4 
was suppressed by 1 M sorbitol (data not shown). In 
agreement with these results, nod, not3 and not4 alleles 
were sensitive to staurospotine, an inhibitor of PXC1. 
indicative of cell wall defects. Moreover, notl, not2 
and not4 alleles were sensitive to 0.04% SDS, another 
phenotype indicative of a defect in cell wall integrity 
(Igual et aL. 1996) also displayed by ccr4, cafl and dbfl 
alleles (data not shown). Furthermore, notl. not2 and not4 
alleles were sensitive to high concentrations of the divalent 
cation. Mg2*, as are ccr4~, cafl- and diy2-containing 
strains (Table II). These results indicate that defects in the 
NOT factors result in phenotypes consistent with the NOT 
proteins functioning in processes similar to CCR4, CAFI 
and DBF2.
The CCR4 complex has positive and negative 
effects on gene transcription
To address whether the CCR4 complex components can 
act as repressors in a manner similar to that observed for 
the NOT proteins, we examined the effect of ccr4. cafl 
and dbfl defects on FUSl-lacZ  expression. Mutations in 
HOT genes result in increased expression of the FUS1 
gene or the FVSl-lacZ  reporter gene in the absence of 
pheromone stimulation (Cade and Enedc, 1994; Coilart 
and Struhl, 1994; Irie et aL, 1994). As shown in Figure 7A, 
deletion of CAFI caused a 5-fold increase in (5-gaIactosid- 
ase activity from the FUSl-lacZ  reporter, while deletion of
CCR4 and DBFZ resulted in an increase of ^ -galactosidase 
activity of -2 -  and 3-fold, respectively. These results are 
similar to die 2- to 5-fold effects observed for the not 
effects on the FUS1 promoter. The ccr4, cafl and dbfl 
effects on the FUSl-lacZ  reporter were specific to the 
FVS1 promoter since ccnf. cafl and dbfZ had very different 
effects on other lacZ reporters carrying different promoters 
(see below).
To extend the comparison of the NOT proteins and the 
CCR4 compiex components, we examined the effects of 
their mutations on several other reporter genes. All reporter 
genes, including the FUSl-lacZ reporter, are derived 
from a UAS-less lacZ reporter. As shown in Figure 7B, 
mutations in the NOT  genes, CCR4 and CAFI resulted in 
decreased expression of the CYCI-lacZ reporter gene 
(dependent on the HAP2, 3, 4 and 5 activator complex), 
in which the ccr4, cafl and notl alleles had the greatest 
effects. The effect on CYCI-lacZ expression was more 
severe when cells were supplied with a oon-fermentable 
carbon source, such as ethanol and glycerol, than with 
glucose, but ccr4, cafl and not3 also had effects under 
glucose growth conditions. The observed effects on the 
derepressed expression of the CYCI-lacZ reporter was 
not due to general effects on the plasmid or lacZ expression 
since the FKSl-lacZ  reporter was largely unaffected 
under non-fermentative growth conditions by these same 
mutations (Figure 7C). These data confirm that, as 
observed with effects on ADH2 expression, the NOT genes 
can also be involved in the activation of gene transcription.
Though the NOT  genes and CCR4 behave similarly, 
some variations in their effects on gene transcription were 
observed when we examined other lacZ reporter genes. 
In the case of HO-lacZ expression, notl, not2. not4 and 
dbfl defects increased (5-galactosidase activity while the 
strains containing deletion of ccr4, cafl or noil showed 
reduced (3-galactosidase activity (Figure 7C). When the 
FKSl-lacZ reporter was examined, variation in the effects 
was again observed. The notl, not4 and dbfl alleles caused 
2-fold increases in ()-galactosidase activity, while either 
ccr4 or not3 caused reductions in |J-galactosidase activity
1101
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F i g .  7 .  E f f e c t s  o f  t b e  ccr4. cafl» d £ j 2  a n d  n o r  m u t a t i o n s  o o  r e g u l a t i o n  o f  g e n e  e x p r e s s i o n .  ( A )  ^ - G a l a c t o s i d a s e  a c t i v i t y  i n  s t r a i n s  ( g r o w n  o s  m i n i m a l  
m e d i u m  l a c k i n g  u r a c i l  a n d  s u p p l e m e n t e d  w i t h  8 %  g l u c o s e )  c a r r y i n g  a  p l a s m i d - b o r n e  FU Sl-lacZ  r e p o r t e r  g e n e  w i t h o u t  p h e x o f f l o n e  f f m t n l a r i o n .  
V a l u e s  a r e  a v e r a g e s  f o r  a t  l e a s t  f i v e  t r a n s f o r m a n t s ,  a n d  t b e  s a n d a r d  e r r o r  o f  t h e  m e a n  ( S E M )  w a s  < 2 0 %  e x c e p t  f o r  s o r a i n  E G Y 1 8 8  i n  w h i c h  i t  w a s  
3 5 % .  w t .  E G Y 1 8 8 :  dbfl. E G Y 1 8 8 - d 2 ;  card. E G Y 1 8 8 - 1 - 1 :  a n d  cafl, E G Y l 8 8 - c l - l .  ( B )  ( S - G a l a c t o s i d a s e  a c t i v i t y  i n  s t r a i n s  c a r r y i n g  a  p l a s m i d - b o r n e  
CYCJ-t'arZ r e p o r t e r .  L G 2 6 5 U P I .  c o n t a i n i n g  t b e  u p s t r e a m  e l e m e n t  f o r  t h e  H A P 2 . 3 .  4  a n d  5  a c t i v a t o r  ( G u a r e n t e  a n d  M a s o n .  1 9 8 3 ) .  T h e  u p p e r  p a n e l  
d i s p l a y s  t b e  e f f e c t s  o f  e c r t f .  cafl a n d  dbfl m u t a t i o n s  o n  t b e  e x p r e s s i o n  o f  t b e  CYCI-lacZ r e p o r t e r  w h i l e  t b e  l o w e r  p a n e l  g i v e s  t h e  e f f e c t s  o f  t b e  not 
m u t a t i o n s  o n  e x p r e s s i o n  o f  t h e  s a m e  r e  p o n e s .  V a l u e s  a r e  a v e r a g e s  f o r  a t  l e a s t  f o u r  t r a n s f o r m a n t s ,  a n d  t b e  S E M  w a s  < 2 5 %  f o r  g l u c o s e - g r o w n  c u l t u r e  
w h e r e a s ,  f o r  n o n - f e r m e u a t i v e  c u l t u r e  t h e  S E M  w a s  < 3 0 % .  e x c e p t  f o r  s t r a i n s  E G Y 1 8 8 - 1 - L  a n d  E G Y l 8 8 - c i - I  i n  w h i c h  i t  w a s  < 5 0 % .  S t r a i n s  o s e d  
f o r  t b e  u p p e r  p a n e l s  f o r  ( B ) ,  ( C )  a n d  ( D )  a r e  t h e  s a m e  a s  ( A ) ,  a n d  f o r  t b e  l o w e r  p a n e l s  g r a m *  a r e :  w t ,  K Y 8 0 3 ;  n o tl.  M Y 8 :  not2. M Y 1 6 ;  notS. 
M Y 2 5 :  a n d  not4. M Y 2 0 .  ( C  a n d  O )  T h e  s a m e  e x p e r i m e n t s  a s  ( 3 )  e x c e p t  c h a t  t h e  CYCI-lacZ r e p o r t e r  w a s  r e p l a c e d  b y  e i t h e r  a  HO-iacZ  r e p o r t e r  
[ c o n t a i n i n g  t b e  c o m p l e t e  u p s t r e a m  s e q u e n c e  o f  t b e  HO  g e n e ,  p l a s m i d  B A 1 6 1  ( B r e e d e n  a n d  N a s m y t h .  1 9 8 7 ) ]  ( Q  o r  a  FK Sl-lacZ  r e p o r t e r  ( p l a s m i d  
p F 7 1 2 - 3 8 0 .  I g u a i  et aL. 1 9 9 6 )  ( D ) .  V a l u e s  a r e  a v e r a g e s  f o r  a t  l e a s t  t h r e e  t r a n s f o r m a n s .  a n d  t h e  S E M  w a s  < 2 2 % .
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(Figure 7D). The not2, and cafl alleies showed less 
dramatic or no effects on FKSl-lacZ  expression. These 
results indicate that different components of the CCR4 
complex have similar but not necessarily identical effects 
on gene expression.
We also analyzed the effect of cafl and ccr4 defects 
on HIS3 gene expression under conditions when the GCN4 
activator is disabled. Using strain KY803, in which not 
mutations cause resistance to 20 mM 3-aminotriazole 
(3AT) whereas the parent strain is sensitive (Collart and 
Struhl, 1994) (Table It), we deleted CCR4 and CAFI. A 
ccr4 disruption in this strain background did not result in 
any enhanced HISS expression and resistance to 20 mM 
3AT whereas a cafl disruption resulted in weak growth 
at 20 mM 3AT. indicative of a slight increase in HIS3 
expression (Table H).
Discussion
The NOT negative regulatory complex is physically 
associated with the CCR4 transcriptional 
regulatory complex
Using mass spectrometry, we have identified the 195. 185 
and 116 kDa species of the CCR4 complex. The 195 and 
185 kDa species were found to be NOTl and the 116 kDa 
species was found to be NOT3. The 185 kDa species is 
an apparent degradation product of NOT1 and is missing 
-100 amino acids from the N-term inus. The 195 and 
185 kDa species were also shown to react specifically 
with an antibody raised against a GST-NOT1 fusion 
protein. The NOT1 and NOT3 proteins are part of the 
NOT negative regulatory complex containing four proteins 
(NOT1, NOT2, NOT3 and N0T4) (Collart and Struhl, 
1994). We subsequently showed by co-immunoprecipi- 
tation that the NOT2 and NOT4 proteins were also 
associated with the CCR4 complex. The interactions 
between the NOT proteins and the CCR4 complex were 
also confirmed by two-hybrid analysis (Table It). These 
results imply that there exist multiple interactions among 
these components and provide additional evidence that 
NOT proteins are part of the CCR4 complex. Recently, 
another component of the NOT complex, the NOTS 
protein, has been found to be functionally and physically 
associated with the other NOT proteins (Oberholzer and 
Collart. 1998). We have since shown that NOT5 also 
specifically co-immunoprecipitares with CCR4 and CAFI 
(Figure 4B; data not shown), suggesting that it too is part 
of the CCR4-NOT complex.
We also showed that NOTl, CCR4 and CAFI co­
purified through three different chromatographic steps 
using a CAFl-6His fusion to aid in the isolation of the 
CCR4 complex. This purified CCR4 complex containing 
the CAFl-6His fusion was eluted from a Superose 6 
column with an estimated moL wt of I T x  IQ6 Da. During 
the purification, the majority of CCR4 was found to be 
associated with CAFl-6His. Determination of the size of 
the CCR4 complex by gel filtration from a wild-type 
strain indicated that CCR4 and CAFI were part of large 
complexes with estimated mol. wts of 1.9x10s and 
l.Ox 10s Da. We have not been able to isolate the 1.9X 10s 
Da CCR4 complex using the 6His-tagged CAFI or CCR4, 
partly as the result of reduced levels of the 1.9 x10s Da 
complex in these strains (unpublished observations). It is
also possible that we would not be able to isolate the 
larger CCR4 complex using the methodology employed 
in this report.
These findings confirm that the CCR4 complex is truly 
a multi-subunit complex. The immunoprecipitation results, 
the co-purification of NOTl with the CCR4 complex, the 
two-hybrid analysis and the previous studies on die NOT 
complex strongly implicate the NOT2, 3 and 4 proteins 
as being components of the 1.2X 10s Da CCR4 complex, 
which can be considered the cote CCR4-N0T complex. 
It remains possible, however, that other forms of the NOT 
complex may exist, especially since a previously identified 
NOT complex was found to be only 6X105 Da in size 
(Coilart and Struhl, 1994).
By several criteria, the CCR4 complexes appear distinct 
from the yeast holoenzyme. First, neither CCR4 nor CAFI 
were found to be in purified preparations of the yeast 
holoenzyme (Draper er aL, 1995). Second, SRB5 migrated 
in a complex that was slightly smaller than the I.9X 10s 
Da CCR4 complex (Figure 5B). Third. SRB proteins did 
not co-purify with the I.2X 10s Da complex. A number 
of other proteins were checked for their presence in 
the 1.2x10s Da complex or for their ability to co- 
immunoprecipitate with CCR4 or CAFI. RPB1, MOT1, 
SPT6, SPT10. ADA2. SIN3. SIN4 and several SNF/SWI 
proteins were all shown not to be part of the CCR4 
complex (Denis et aL, 1994, unpublished observations). 
These results place the CCR4 complex, containing tbe 
NOT proteins, as a unique and novel transcripdonal 
regulatory group of proteins.
The role of the CAFI protein in this complex was 
elucidated partly through die analysis of the effects of 
cafl defects on the association of CCR4 protein with the 
complex. Disruption of cafl effectively removed CCR4 
protein from the 1.9x10s and 1.2x10s Da complexes. 
Correspondingly. CCR4 did not immunoprecipitate well 
with the NOT proteins in a cafl background. In contrast, 
a ccr4 disruption did not affect CAFI immunopredpitarion 
with the NOT proteins (Figure 3B) nor did it affect CAFI 
association in the 1.9x10s Da complex (unpublished 
observation). These data indicate that CCR4 association 
in the complex depends on the presence of CAFI. Consist­
ent with this conclusion is the observation that high copy 
expression of CCR4 can complement a cafl defect (Hara 
etaL, 1997); increased levels of CCR4 would be able to 
associate by mass action in the CCR4 complex even in 
the absence of CAFI. High copy expression of CAFI 
cannot complement a ccr4 defect (Hata etaL, 1997), 
however, apparently because CCR4 plays an essential role 
that increased levels of CAFI cannot duplicate.
The NOT complex is functionally associated with 
the CCR4 complex
The previous studies on the HOT genes clearly demon­
strated that they played a negative regulatory role in gene 
transcriprion. Our finding that this complex physically 
associates with the CCR4 complex would suggest that it 
should also be positively involved in gene transcriprion. 
By examining the defects of the HOT genes on ADH2 
expression, we were able to demonstrate that mutations 
in the HOT genes, with the exception of HOT3. caused 
a reduction of ADH2 gene expression under glucose- 
derepressed conditions. This result not only establishes
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functional similarity between tbe NOT proteins and those 
in. the CCR4 complex bur also suggests that the NOT 
complex is involved in activation of gene transcription.
A positive role for the NOT complex in gene transcrip­
tion was demonstrated further by the observation that a  
not4 disruption suppressed the ability of an sptlO mutation 
to cause enhanced ADH2 expression under glucose growth 
conditions. The only other known alleles which confer 
this phenotype are ccr4. cafl and dbfl, all components of 
the CCR4 complex (Liu et aL, 1997). Moreover, the 
expression of the CYCI-lacZ reporter gene, containing 
the upstream binding site for the HAPZ 3, 4  and 5 
p r o t e i n s ,  was reduced by defects in the NOT genes. In 
this case, the defects in the NOT genes reduced CYCI- 
lacZ expression as did defects in CCR4 and CAFI. This 
reduction of CYCI-lacZ expression by the not alleles 
occurred primarily under non-fennentative growth condi­
tions. I .ike CCR4 and CAFI. the NOT proteins may 
play a special role in aiding the expression of non- 
fermentarive genes.
In addition to their similar effects on non-fennentative 
gene expression, the CCR4 complex components and 
the NOT proteins shared other phenotypic similarities. 
Mutations in all of these genes except that of NOT3 
resulted in increased caffeine sensitivity. This phenotype 
appears to be the result of impaired formation of the cell 
wall (Levin and Bartlett-Heubusch, 1992). Moreover, the 
cold-sensitive phenotype of ccr4 and the ts phenotypes of 
dbf2, cafl. not! and not4 were all suppressed by osmotic 
stabilizing agents such as sorbitol, c o n f i r m i n g  a defect 
caused by the alleles in terms of cell wall integrity. ccr4, 
cafl. dbf2, nod. nod  and not4 alleles were also sensitive 
to staurospotine, indicative of a cell wall integrity problem. 
Increased sensitivity to mono- and divalent cations is also 
a phenotype associated with ccr4, cafl and dbfl alleles, 
and a similar sensitivity was observed for the not alleles.
Whereas the CCR4 complex previously had been 
ascribed a positive role in gene expression, its association 
with the NOT proteins implicates them in affecting gene 
expression in a negative way as well. Previous data have 
indicated chat ccr4 mutations can negatively affect gene 
expression in the methionine biosynthetic pathway 
(McKenzie e ta l ,  1993). In this case, a ccr4 mutation 
acted in a  manner similar to such other negative regulators 
as SPT21. RPD3 and RPD1 (SIN3). Also, ccr4 and 
cafl alleles cause increased resistance to X-ray radiation, 
presumably by releasing negative control of genes involved 
in the RADSI and RADS2 pathway (Schild. 1995). Further­
more, the original identification of a cafl mutation (pop2) 
involved its negative control of PGK1 expression during 
stationary phase (Sakai etaL, 1992). We further showed 
that CCR4. CAFI and DBF2 negatively affect FUSl-lacZ  
expression in the same manner as did the NOT genes 
(Cade and Errede, 1994; Collart and Struhl, 1994). These 
observations indicate that the CCR4 complex components, 
like the NOT proteins, can play negative roles in control­
ling gene expression. Therefore, the protein association 
of the NOT proteins with components of the CCR4 
complex results in overall similar control of gene expres­
sion and other processes.
Notwithstanding the above-described similarities, the 
CCR4, CAFI, DBF2 and NOT genes were found to differ 
in their effects in some cases. This was observed most
1104
T a b l e  I I L .  Y e a s t  s t r a i n s
S t r a i n s R e l e v a n t  g e n o t y p e s
8 0 8 - 5 c MAj Oj sptl0::LEU2 umS his3 U ul o p l
K Y 8 0 3 MATct crpl&J a m i - 5 2  gcn4 Uu2::PBT56
K Y 8 G 3 - L - 1 i s o g e n i c  t o  K Y 8 Q 3  e x c e p t  ccr4::C/RAJ
K Y 8 0 3 - c i - l i s o g e n i c  ’jo K Y 8 0 3  e x c e p t  ccfl::LEU2
M Y S i s o g e n i c  a s  K Y 8 0 3  e x c e p t  n o r / * 2  a n d  A f X T a
M Y 1 6 i s o g e n i c  t o  K Y S 0 3  e x c e p t  notl~ \
M Y 2 5 i s o g e n i c  c o  K Y 8 0 3  e x c e p t  notS~2
M Y 5 0 8 i s o g e n i c  t o  K Y 8 0 3  e x c e p t  not3::URA3
M Y 5 3 7 i s o g e n i c  a s  K Y 8 Q 3  e x c e p t  rtot4::URA3
K Y S Q 3 - A 3 i s o g e n i c  c o  K Y 8 0 3  e x c e p t  adhi::URA3
M Y S - A l i s o g e n i c  t o  M Y S  e x c e p t  adrJ::URA3
M Y L 6 - A 1 i s o g e n i c  t o  M Y 1 6  e x c e p t  adhI::URAJ
M Y 2 5 - A 1 i s o g e n i c  c o  M Y 2 5  e x c e p t  adhl::URA3
6 1 2 - l d - o 4 MATa cd h l-il x r e J  his3 trp i leu2 r*ot4::URA3
E G Y 1 8 3 A £ A X a  ad kl-Il ura3 his3 trp i LexA—LEUl
E G Y 1 8 8 - C I o o g e n i c  t o  E G Y 1 8 8  e x c e p t  ca fl:: URA3
E G Y 1 8 8 - I i s o g e n i c  t o  E G Y 1 8 8  e x c e p t  ccr<::URA3
E G Y 1 8 S - 4 2 i s o g e n i c  t o  E G Y 1 8 8  e x c e p t  dbf2scLEU2
obviously with the HO-lacZ and FKSl-lacZ  reporter 
genes and with HIS3 expression. These data suggest that 
although all the CCR4 complex components can share 
common functions, the individual components of this 
complex can behave differently in regulating different 
genes.
The feet that these various proteins can affect expression 
both positively and negatively suggests that the role of 
CCR4, CAFI and the associated NOT proteins may be 
more versatile than previously indicated. The demonstra­
tion that CCR4 acts at the ADH2 locus at a post-chromatin 
remodeling step (Verdone e ta l, 1997) is consistent with 
the model that the NOT proteins act to regulate TATA 
box-binding protein (TBP) use of non-consensus TATAA 
sequences (Collart and Struhl, 1994; Collart, 1996). The 
function of the CCR.4—NOT complex is also clearly 
affected by the sequences that lie upstream of the TAXAA 
(Figure 7). It is likely that sequence-specific activator 
binding or chromatin structure influences the NOT proteins 
and other CCR4 complex components in their mode of 
action. Because of the size of the CCR4 complex and the 
number of its components, it is highly likely that individual 
factors, while showing overall functional similarity to 
other components in the complex, will play somewhat 
different roles in transcription. Individual proteins may be 
the targets of different regulatory factors and regulatory 
processes. For instance. DBF2 is a cell cycle-regulated 
protein kinase, and defects in DBF2 cause a telophase 
block. CAFI and CCR4 are themselves not cell cycle 
regulated, and mntadons in them cause only a partial 
late mitotic defect (Liu eta l, 1997). Clearly, the CCR.4 
transcriptional complex does not act by itself, and identify­
ing its contacts with the several other known protein 
complexes involved in transcription remains a major focus 
to understanding how the CCR4 complex and its individual 
proteins function.
Materials and m ethods
S tra in s and  c u l t u r e
Y e a s t  s t r a i n s  a r e  L is te d  i n  T a b l e  m .  G r o w t h  o c  Y D  s o l i d  m e d i u m  w a s  
d o n e  w i t h  P e t r i  p l a t e s  c o n t a i n i n g  Y E P  ( 1 %  y e a s t  e x t r a c t  a n d  2 %
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b a c t o p e p t o c e )  s u p p l e m e n t e d  w i t h  2 %  g l n s o v :  a n d  2% b a c t o a g a r .  £ -  
G a l a c t o s i d a s c  a s s a y s  w e r e  c o n d u c t e d  a s  d e s c r i b e d  ( C o c k  e ta l. 1 9 9 4 )  
o n  n c n f m a l  m e d i u m  l a c k i n g  u r a c i l  t h a t  w a s  s u p p l e m e n t e d  d t b e  w i t h  
8 %  g j n c o s c  o r  w i t h  2 %  e a c h  o f  g l y c e r o l  a n d  e t h a n o l .  A D H  H  a s s a y s  
w e r e  c o n d u c t e d  a s  d e s c r i b e d  ( C o c k e r e l .  1 9 9 4 ) .
Im m unopredpita tion
I m m u n o p r e t i p i a t i o a s  w e r e  r*rn+A o u t  a s  d e s c r i b e d  p r e v i o u s l y  ( D i a p e r  
etaL. 1 9 9 4 ;  L i u  etcL. 1 9 9 7 ) .  T o  i s o l a t e  t b e  C C R 4  c o m p l e x  f o r  p r o t e i n  
s e q o e n d n g .  y e a s t  w h o l e  c e i l  e x t r a c s  p r e p a r e d  f r o m  a  4 0 0  m l  o v e r n i g h t  
c u l t u r e  w e r e  m i x e d  w i t h  2 0  p i  o f  a f f i n i t y - p u r i f i e d  L e x A  a n d b o d y  f b r  
4 5  m i n .  T o  t h i s  w a s  a d d e d  3 0 0  p i  o f  a  5 0 %  p r o t e i n  A - a g a r o s e  s l u r ,  a n d  
d s e  i n c u b a a o n  w a s  c o n t i n u e d  f b r  a n  a d d i a o c a l  5 0  m i n .  T h e  r e s u l t i n g  
; « w n t m Q p r e o ' p i f 9 f ^  w a s  t e g U Sp e o d s d  U t  1 5 0  p i  o f  2 X  S D S  c w n p h -  o u f f r ;  
a n d  b o i l e d  f o r  5  m i s .  T b e  s a m p l e  w a s  d i v i d e d  a n d  l o a d e d  o n t o  t h r e e  
l a n e s .  A f t e r  d c c t i o u h c r e s i s .  t h e  g e l  w a s  s a i n e r t  i n  C o o m a s s i e  b l u e  
s o l o c i o a  f o r  2  h  a n d  d e s r a i n e d  o v e r n i g h t .  T b e  p r o t e i n  b a n d s  o f  m a r c s :  
w e r e  e x c i s e d  a n d  s u b j e c t e d  t o  m a s s  s p e c t r o m e a r i c  a n a l y s i s .  I m m u n o b l o t  
a n a l y s i s  w a s  c a r r i e d  o u t  a c c o r d i n g  t o  d i e  d e s c r i b e d  p r o c e d u r e s  ( L i u  
etaL. 1 9 9 7 ) .  T b e  i m m u n o b l o t  r e s u l t s  w e r e  a n a l y z e d  b y  a n  A r c u s  H  
■ S c a n n e r  ( A g f a - G e v a e r t .  N . V . .  U K )  a n d  A d o b e  P h o t o s h o p  3 . 0  ( A d o b e  
S y s t e m s  I n c .  U S A ) .
P rotein ttentffTcatidn by mass spectrometry
T e c h n i q u e s  a n d  s t r a t e g y  o f  a n a l y s i s  w e r e  a s  p r e v i o u s l y  d e s c r i b e d  
( S h e v c h e n k o  e ta l, 1 9 9 6 ) .  G e l  p i e c e s  w e r e  w a s h e d ,  ‘ i n - g e l ’  r e d u c e d .  S -  
a l k y l a c e d .  a n d  p r o t e i n  e n z y m a t i c a l l y  d e g r a d e d  w i t h  t r y p s m  a s  d e s c r i b e d  
( W U m  et aL. 1 9 9 6 ) .  A f t e r  3  h .  - 2 %  o f  t h e  d i g e s t  p r o d u c t  w a s  a p p l i e d  
o n  a  m i c r o - c r y s t a l l i n e  l a y e r — a  m i x t u r e  o f  a - c y a n o - 4 ~ b y d r o x y c x n n a m i c  
a d d  a n d  n i t r o c e l l u l o s e  ( J e n s e n  et aL.  1 9 9 6 ) -  a n d  a n a l y z e d  b y  M A L D I -  
t i m e  o f  f l i g h t  m a s s  s p e c t r o m e t r y .  T b e  m a s s  s p e c a o t n e t e r  ( B r u k e r  R e f l e x .  
B n i t o - F c a n z c c .  B c n a e a .  G e r m a n y )  w a s  e q u i p p e d  w i t h  d e l a y e d  i o n  
e x t r a c t i o n .  F o r  p e p t i d e  s e q u e n c i n g  b y  o a n o e l e c s o s p r a y  m a s s  s p e c t r o ­
m e t r y .  t h e  r e m a i n i n g  p r o d u c t  w a s  e x t r a c t e d ,  c o n c e n t r a t e d  a n d  d e s a l t e d  
o n  a  1 0 0  n i  R 2  P c r o s  m i c r o c o l u m n .  a n d  e l u t e d  i s  2 X 0 . 5  p i  o f  6 0 %  
m e t h a n o l .  5 %  f o r m i c  a r i d  i n t o  a  n a n o e l e c t r o s p r a y  s p r a y i n g  n e e d l e  a s  
d e s c r i b e d  ( W i l m  a n d  M a n n .  1 9 9 6 :  W i l m  etaL , 1 9 9 6 ) .  A n a l y s e s  w e r e  
p e r f o r m e d  o c  a  t r i p l e  q u a o r u p o l e  m a s s  s p e c t r o m e t e r  ( A P I  I K .  P e d r i n -  
E l m e r  S r i e x ,  T o r o n t o .  C a n a d a ) .  D a t a b a s e  s e a r c h e s  b y  p e p t i d e  m a s s  m a p s  
a n d  b y  p e p t i d e  s c q u m c n  t a g s  ( M i n n  a n d  W H m ,  1 9 9 4 )  w e r e  p e r f o r m e d  
w i t h  t h e  p r o g r a m  P e p d d e S c a i c h  u s i n g  a  c o m p r e h e n s i v e  n o n - r e d c n d a n c  
d a t a b a s e  c u r r e n t l y  c o n t a i n i n g  > 2 3 0  0 0 0
P urification o f the  CCH4 com plex
Y e a s t  w h o l e  c e l l  e x t r a c t s  w e r e  p r e p a r e d  b y  a  m o d i f i c a t i o n  o f  t h e  m e t h o d  
o f  L i u  e r  aL ( 1 9 9 7 )  i n  w h i c h  3 X  b u f f e r  A  [ 5 0  m M  T r i s - O A c ,  p H  7 9 /  
1 5 0  m M  K O A c / 2 0 %  g l y c e r o l / 0 . 2 %  T W e e a - 2 0 / 2  m M  B - m e r e a p o e d i a a o l  
( B - M E ) / 2  m M  M g O A c  p l u s  p r o t e a s e  i c i r i b t t o c s ]  w a s  u s e d  c o  r e s u s p e n d  
c e l l  p e l l e t s  ( 1 4 0  g  o f  w e t  c e l l s ) .  T h e  c l e a r  e x t r a c t  ( 1 2 0  m i )  w a s  a p p l i e d  
t o  a  4  m l  N i 2 "**-N T A  c o l u m n .  T h e  b o u n d  p r o t e i n s  w e r e  e l u t e d  i n  2 5 0  m M  
i m i d a z o l e  i n  b u f f e r  A .  T b e  r e s u l t i n g  N t 2 * ’ e l u a t e  ( 1 2  m l )  w a s  a p p l i e d  t o  
a  M o n o  Q  K R 5 / 5  c o l u m n  a n d  d i e  p r o t e i n  f r a c t i o n s  w e r e  t h e n  e l u t e d  i n  
a  2 0  m l  l i n e a r  1 0 0 - 2 0 0 0  m M  g r a d i e n t  o f  K O A c  i n  b u f f e r  B :  5 0  m M  
T r i s - O A c .  p H  7 . 9 / 1 0 0  m M  K O A c / 2 0 %  g i y c e r o l / Q . Q 2 %  T w e e a - 2 G / 1  m M  
& - M E / 2  m M  M g O A c / 1  m M  H D T A .  p l u s  p r o c e a s e  i n h i b i t o r s  i n c l u d i n g  
2  p i / m l  o f  l e u p e p d n  Cl m g / m l ) ,  p e m t a n n  A  ( 1  m g / m l ) ,  c h y m o s t a t i n  
( 5  m g / m l )  a n d  b e c z a m i d i n e  ( 5 0 0  m M ) .  a n d  1 0  j i L t a i  o f  5 0 0  m M  
p h e n y l m e t h y l s u l f o c y l  f l u o r i d e  ( P M S F ) .  T h e  f r a c r i o o s  c o n t a i n i n g  C C R 4  
a n d  C A F l - 6 H i s  w e r e  p o o l e d  ( 2  m l  i n  t o t a l )  a n d  s u b j e c t e d  t o  u l t r a f i l t r a t i o n  
u s i n g  a  C e n t r i c o n  1 0  d e v i c e  ( A m i c o n .  M A ) .  T h e  c o n c e n t r a t e d  p r o t e i n  
s a m o l e  ( 2 0 0  j i l )  w a s  a p p l i e d  t o  a  S u p e r o s e  6  H R . 1 0 / 3 0  c o l u m n  e c u i l l b r a t e d  
i n  b u f f e r  G  ( 5 0  m M  T r i s - O A c .  p H  7 . 9 / 1 5 0  m M  K O A c / 1 0 %  g l y e e r e l /  
0 . 0 2 %  T w e e n - 2 0 / 1  m M  d i t h i o t h r r i t o l / l  m M  H D T A / 2  m M  M g O A c )  p l u s  
p t o t e a s e  i n h i b i t o r s .  T b e  p r o t e i n  f r a c t i o n s  w e r e  c o l l e c t e d  a s  0 - 5  m i /  
f r a c t i o n  a n d  s t o r e d  a t  - 8 0 * C  w h i l e  p a r t  o f  t h e  m a r e n a i s  ( 1 0  p i  f o r  N i 2 * -  
N T A  a n d  M o n o  Q  e l u a t e .  a n d  2 5  p i  f o r  S u p e r o s e  6  f r a c t i o n s )  w a s  
s u b j e c t e d  t o  i m m u n o b l o t  a n a l y s i s  m m g  C C R 4 .  C A F I  a n d  N O T 1  a n h -  
b o d i e s .
Gel filtration chromatography
T b e  S u p e r o s e  6  c o l u m n s  H R l Q / 3 0  a n d  H R I 6 / 5 0  w e r e  p a c k e d  w i t h  
S u p e r o s e  6  m e d i a ,  p r e p  g r a d e ,  a c c o r d i n g  t o  t h e  m a n u f a c t u r e r ' s  i n s t r u c ­
t i o n s  ( P h a r m a c i a ) .  A  m o l e c u l a r  w e i g h t  s t a n d a r d  m i x t u r e  w a s  u s e d  9  
c a l i b r a t e  t h e  S u p e r o s e  6  c o l u m n s .  T h e  c a l i b r a t i o n  f b r  t b e  S R 1 Q / 3 0  
c o l u m n  i n  b u f f e r  G  p l u s  p r o t e a s e  i n h i b i t o r s  w a s :  e x c l u s i o n  v o l u m n  ( b l u e  
d e x c r a n .  2 0 0 0  k D a )  a t  1 0  m i :  t h y r o g l o b u l i n  ( 6 6 9  k D a )  a t  1 5  m l :  b o v i n e  
s e r u m  a l b u m i n  ( B S A )  ( 6 6  k D a )  a t  1 7 . 5  m L  F o r  t h e  H R 1 6 / 5 0  c o l u m n .
t h e  c a l i b r a t i o n  w a s :  b l u e  d e x t r a n  a t  3 8 . 6  m l :  t b y r o g l o b u l i n  a t  5 9  mL* 
a m y l a s e  ( 2 0 0  k D a )  a t  6 5  m l :  B S A  a t  6 9  m l ;  c a r b o n i c  a n h y d r a s e  ( 2 9  k D a )  
a t  7 2 . 7  m L
T o  a n a l y z e  t b e  C C R 4  c o m p l e x  u s i n g  g e l  f l l t r a d o n  c h r o m a t o g r a p h y ,  
y e a s t  w h o l e  c e l l  e x t r a c t s  p r e p a r e d  f r o m  a  5 0 0  m l  o v e r n i g h t  g l u c o s e -  
g r o w n  c u l t u r e  i n  3 x  b u f f e r  A  w e r e  f i r s :  c l a r i f i e d  b y  u l E m c c n r r i f u g a d o n  
i n  a  S W 6 5  r o t o r  a t  4 5  0 0 0  c p m u  f o r  6 0  a x i s .  T h e n  2 0 0  p i  o f  t h e  d e a r  
e x t r a c s  w e r e  l o a d e d  o o t o  a  S u p e r o s e  6  c o l u m n .  T h e  r e s u l t i n g  I  m l  
f r a c t i o n s  w e r e  s u b j e c t e d ,  c o  W e s t e r n  b l o c  a n a l y s i s .  F o r  t h e  D N a s e  
c e a a n c n t  e x p e r i m e n t s ,  y e a s t  w h o l e  e x f r z c t s  w e r e  p r e p a r e d  i n  Z D T A -  
f r e e  3x  b u f f e r  A .  A f t e r  a l t i a e e n t r i f u g a a o n .  7 - S  p i  o f  D N a s e  I  ( 6 1 . 5  p g /  
m i )  w e r e  a d d e d  t o  I  m l  o f  t h e  c l e a r  e x f f a c r s  a n d  t h e  m i x t u r e  w a s  
i n c u b a t e d  a t  r o o m  c e m p e x a m r e  f b r  ?  m i n -  T h e n  2 0 0  p i  o f  t b e  m i x t u r e  
w a s  a n a l y z e d  o o  t b e  S u p e r o s e  6  c o l u m n  a n d  3 0  p i  c f  t h e  I  m l  f r a c t i o n s  
w e r e  s u b j e c t e d  t o  i m m u n o b l o t  a n a l y s i s .
A cknow ledgem ents
W e  w i s h  t o  t h a n k  Z C S t x u h L  B - E r r e d e .  L - J o h n s o n .  J - M a  a n d  M C o l l a r r  
f o r  p r o v i d i n g  s t r a i n s  a n d  p l a s m i d s  u s e d  i n  t h i s  s t u d y .  M - C o l l a r t  f o r  
N O T S  a n t i b o d y ,  a n d  T . L c c  f o r  h i s  g i f t  o f  N O T !  a n t i b o d y .  T h e  t e c h n i c a l  
a s s i s t a n c e  o f  Y L * C C h t a n g  a n d  I F c r r e l l  i s  a l s o  a p p r e c i a t e d .  J J L  a c k n o w ­
l e d g e s  s u p p o r t  f r o m  t h e  F o o d s  d e r  C h e m i s c h e a  Q i c m x e .  W o r k  i n  t h e  
p r o e m  a n d  P e p t i d e  G r o u p  ( E M B O )  i s  s u p p o r t e d  p a r t i a l l y  b y  g r a n t s  
f r o m  t h e  G e r m a n  T e c h n o l o g y  M i n i s t r y  ( B M B F )  a n d  G l a x o  W e l l c o m e .  
T h i s  r e s e a r c h  w a s  s u p p o r t e d  b y  N T H  g r a n t  G M 4 1 2 1 5 .  N S F  g r a a r  
M C B 9 5 - 1 3 4 1 2 .  a n d  H a t c h  p r e s e t  2 9 1  t o  C L P .  T h i s  i s  p u b l i c a t i o n  
1 9 6 9  f r o m  T h e  N e w  H a m p s h i r e  A g r i c u l t u r e  E x p e r i m e n t  S t a r i o o .
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